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Abstract 
Ribosome biogenesis is a crucial yet poorly understood and complex process in all cells. To date, 
most studies on eukaryotic ribosome biogenesis have relied on yeast genetics and whole cell 
analysis of ribosomal RNA processing. An early and critical step in ribosome biogenesis is the 
post-transcriptional modification of rRNA. Pseudouridylation is the most frequently occurring 
modification. Pseudouridylation is catalyzed by H/ACA small nucleolar ribonucleoproteins 
(snoRNPs) which are one of the two major classes of snoRNPs found within eukaryotes and 
archaea. H/ACA snoRNPs consist of four conserved core proteins Cbf5, Gar1, Nop10, and Nhp2 
(eukaryotes), and a substrate specific H/ACA snoRNA. Mutations causing the rare inherited 
disease Dyskeratosis congenita are found in CBF5, NOP10, and NHP2. Here I report the 
purification of H/ACA protein Cbf5 in the presence of detergents. Additionally, I report initial in 
vitro RNA binding studies using Nhp2 and the snoRNA snR34 as well as the effects of 
Dyskeratosis congenita substitutions within Nhp2 on this interaction.  
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I Literature Review 
I.I Ribosome Biogenesis 
One of the most critical and energy consuming tasks encountered by any eukaryotic cell is the 
synthesis and assembly of ribosomes. Occurring successively within the nucleolus, nucleoplasm, 
and cytoplasm, ribosome biogenesis involves more than eighty ribosomal proteins, four 
ribosomal RNAs (rRNA), more than 150 transient accessory proteins and between sixty and two 
hundred small nucleolar RNAs (snoRNA). The eukaryotic 80S ribosome is composed of a small 
40S subunit and a large 60S subunit. The 40S subunit consists of thirty to fifty ribosomal proteins 
and one rRNA, the 18S rRNA [1]. The 60S subunit is made up of forty to fifty ribosomal proteins 
and three rRNAs, the 5S, 5.8S, and 25S rRNAs [1].  
 Ribosome biogenesis begins in the nucleolus with the transcription of a single large pre-
rRNA from tandemly arranged rRNA transcriptional units [2]. Contained within this pre-rRNA 
transcript are the sequences for the mature 18S, 5.8S and 25S rRNAs. However, the 5S rRNA is 
not transcribed from this pre-rRNA transcript, but is transcribed independently [2]. The mature 
rRNA sequences are separated by internal transcribed spacers (ITS1 and ITS2) and external 
transcribed spacers (5’ ETS and 3’ ETS), which are removed through a series of endonucleolytic 
and exonucleolytic cleavage events. In total, ten common cleavage events occur co-
transcriptionally or rapidly after pre-rRNA transcription. The general yeast pre-rRNA cleavage 
pathway is outlined in Figure 1. The 3’ ETS is the first to be removed [3]. Following the removal 
of the 3’ ETS, the pre-rRNA is cleaved at the A0 and A1 sites removing the 5’ ETS producing the 
32S precursor transcript [4]. Cleavage at the A2 site within ITS1 separates the rRNA subunits 
forming the 20S and 27S precursor transcripts [4]. The mature 18S rRNA of the 40S ribosomal 
subunit is produced through the cleavage of the 20S precursor at the D site [5]. The mature 5.8S 
and 25S rRNAs of the 60S ribosomal subunit are formed by the endonucleolytic cleavage of ITS2 
[4]. 
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Figure 1: General pre-rRNA yeast processing pathway. The 18S, 5.8S, and 25S mature rRNA 
transcripts are processed from the 35S pre-rRNA transcript through the removal of internal and external 
transcribed spacer regions (adapted from [2-3, 5] ).   
 During processing, pre-rRNA transcripts undergo extensive covalent chemical 
modifications of nucleotides within the mature rRNA sequences, occurring in functionally 
important regions of the ribosome. The most abundantly occurring chemical modifications are the 
isomerisation of uridines to pseudouridines and the 2’-O-methylation of riboses. Within 
mammalian rRNA, over two hundred nucleotides are modified producing approximately one 
hundred 2’-O-methylated riboses and approximately ninety five pseudouridines, while fifty five 
2’-O-methylated riboses and twenty three pseudouridines can be found in Saccharomyces 
cerevisiae rRNA [6]. Two groups of small nucleolar ribonucleoproteins (snoRNPs) are 
responsible for these modifications in eukaryotes, C/D snoRNPs and H/ACA snoRNPs. C/D 
snoRNPs carry out the 2’-O-methylation of riboses while H/ACA snoRNPs are responsible for 
the isomerisation of uridines into pseudouridines [7]. 
Pseudouridines cluster in functionally important regions of the ribosome. Many 
pseudouridines have been found in the A and P site of the peptidyltransferase centre (PTC) on the 
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large ribosomal subunit whereas no clustering of pseudouridine residues occurs on the small 
ribosomal subunit [8].  
I.II  Pseudouridine  
Pseudouridine is the most abundantly modified base found in most rRNAs, tRNAs, and small 
nuclear RNAs (snRNA). Post-transcriptional modifications of pre-RNA transcripts alter the 
chemical and structural properties of the RNA thus contributing to the function of the RNA. 
Pseudouridine is an isomer of uridine possessing a carbon-carbon rather than a nitrogen-carbon 
glycosidic bond, attaching the ribose to the uracil (Fig. 2).  
 
Figure 2: Structures of uridine and pseudouridine. Following the isomerisation of uridine to 
pseudouridine, uracil is attached to the ribose by a carbon-carbon glycosidic bond instead of a carbon-
nitrogen bond.  
 The altered structure of pseudouridines compared to uridines introduces an extra free 
amino group which can act as an additional hydrogen bond donor [9]. As a free nucleotide, 
pseudouridine adopts a syn glycosyl conformation while an anti conformation is adopted by 
pseudouridines found within oligonucleotides and double helices [10-11]. In the anti 
conformation, pseudouridines confer increased rigidity [9-11]. The anti conformation of 
pseudouridines within RNA offers an appropriate geometry and distance for the formation of a 
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water bridge between the pseudouridine base and the backbone of the preceding residue, 
coordinating the water molecule between pseudouridines N1-H and the 5’-phosphates [12]. The 
presence of a water bridge in turn restricts the conformation and mobility of the backbone 
preceding the pseudouridines [10]. The formation of a water bridge may also enhance the local 
stacking of single-stranded and double-stranded regions of RNA by rigidifying the local 
phosphodiester backbone thus increasing the stacking of neighbouring nucleosides, in turn 
improving the stability of the RNA structure [10]. 
I.III Proposed Pseudouridylation Mechanisms 
Pseudouridine synthases are responsible for the isomerisation of uridines to pseudouridines 
within archaea, bacteria, and eukaryotes. Pseudouridine synthases can be classified into five 
families: RluA, RsuA, TruA, TruB, and TruD. Structural analysis of the five pseudouridine 
synthase families has shown a common core domain and a highly conserved active-site cleft 
containing a universally conserved catalytic aspartate residue [13]. The Escherichia coli TruB 
protein is responsible for the pseudouridylation of uridine 55 within the T- loop of elongator 
tRNAs [14]. Structural analysis of TruB and the H/ACA small nucleolar ribonucleoprotein 
(snoRNP) complex component Cbf5 demonstrated that both share a similar structure, indicating 
that Cbf5 is a member of the TruB pseudouridine synthase family [15]. While Cbf5 possesses 
stand-alone enzymatic abilities, it requires the presence of a substrate specific guide RNA and 
three additional structural proteins to achieve optimal enzymatic activity.  
 The conversion of target uridines to pseudouridines involves three general steps i) the 
cleavage of the N-glycosidic bond between the uracil and ribose ii) the placement of carbon 5 of 
the cleaved uracil residue next to the carbon 1’ of the ribose and iii) the formation of the C1’-C5 
glycosidic bond. While the exact mechanism of pseudouridine formation remains under debate, 
two possible mechanisms have been proposed, the Michael mechanism (Fig. 3A) and the acylal 
mechanism (Fig. 3B).     
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Figure 3: Proposed catalytic mechanisms of pseudouridine formation. A. The Michael mechanism, 
where the catalytic aspartate residue forms a Michael adduct with the uridine (adapted from [18-19]). B. 
The acylal mechanism, where an acylal intermediate is formed by the catalytic aspartate residue (adapted 
from [18-19]).  
The Michael mechanism uses the catalytic aspartate as a nucleophile to form a Michael adduct 
with the target uracil [16-17]. The Michael addition to the uracil enables the N-C glycosidic bond 
to be cleaved allowing the uracil ring to rotate 180° around the new ester bond formed with the 
catalytic aspartate [16-17]. The rotation of the uracil repositions the carbon 5 atom of the uracil 
near the carbon 1’ of the ribose allowing it to form a new C-C glycosidic bond. Subsequent 
removal of the catalytic aspartate and deprotonation of uracil’s carbon 5 completes pseudouridine 
formation [16-17]. During the acylal mechanism, the catalytic aspartate residue forms an acylal 
intermediate through the nucleophilic attack of the ribose carbon 1’ [20-21]. The resulting 
uracilate anion rotates to reposition the uracil carbon 5 and the ribose of carbon 1’ next to each 
other thereby allowing subsequent formation of the C-C glycosidic bond and simultaneous 
removal of the catalytic aspartate [20-21]. Pseudouridine formation is completed with the 
deprotonation of uracil carbon 5.   
I.IV H/ACA Small Nucleolar Ribonucleoproteins   
Eukaryotes and archaea use H/ACA snoRNPs in addition to stand-alone pseudouridine synthases 
to catalyze the sequence-specific pseudouridylation of pre-rRNAs. Identified in the late 1990’s, 
H/ACA snoRNPs are composed of four conserved proteins and a substrate-specific H/ACA 
snoRNA (Fig. 4) [22-23].  
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Figure 4: Structure of Pyrococcus furiosus H/ACA sRNP complex. A. No substrate RNA bound (PDB, 
2HVY [24]). B. H/ACA sRNP with substrate RNA bound (PBD, 3HAY, [25]). The catalytic protein Cbf5 
(purple) and structural protein L7Ae (blue, homolog of eukaryotic protein Nhp2) interact directly with 
H/ACA sRNA (orange). In addition, Cbf5 also interacts with substrate RNA (red) and associates 
independently with structural proteins Nop10 (yellow) and Gar1 (green).   
H/ACA Small Nucleolar RNAs 
The defining feature of all snoRNPs is their snoRNA. Eukaryotic H/ACA snoRNAs fold into a 
conserved ‘hairpin-hinge-hairpin-tail’ secondary structure [23]. The single-stranded hinge region 
and the 3’ tail contain the essential Box H (ANANNA) and ACA sequences, respectively. 
Mutational analysis of the Box H and Box ACA sequence and their spatial arrangement have 
shown that both elements are required for snoRNA stability, localization, and function [23, 26]. 
The Box ACA makes critical RNA-protein contacts with the catalytic protein Cbf5’s 
pseudouridine and archaeosine transglycosylase (PUA) domain [24].   
Within each hairpin structure is a single-stranded motif, the pseudouridylation pocket, 
which is complementary to the sequence of the substrate rRNA around the site of 
pseudouridylation [26]. The specificity of an H/ACA snoRNP complex is determined by the 
pseudouridylation pocket as its single stranded sequence forms Watson and Crick base pairs with 
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three to ten nucleotides of the substrate rRNA. The Watson and Crick base pairing between the 
snoRNA and the substrate rRNA places the target uridine residue within the catalytic pocket of 
Cbf5 [26].  
Found within the upper hairpin of all archaeal and some eukaryotic H/ACA snoRNAs is a 
kink-loop RNA structural motif, a variation of the kink-turn RNA secondary structure element. 
Kink-turns commonly consist of a helix – asymmetric internal bulge – helix structure, where the 
first helical stem, known as the canonical stem (C-stem), ends with two Watson-Crick base pairs 
at the internal bulge and the second helical stem, the non-canonical stem (NC-stem), follows the 
internal bulge with two tandem non-Watson-Crick base pairs (usually sheared A-G base pairs) 
[27]. The asymmetric loop typically contains three unpaired nucleotides on one strand and 
induces a 120
o
 bend in the phosphodiester backbone [27]. This kinking of the phosphodiester 
backbone causes the third unpaired nucleotide, commonly a uridine residue, to protrude into 
solution while A-minor interactions between the two helical stems stabilize the 120
o 
bend [27]. 
This secondary structure motif is recognized and bound by the archaeal H/ACA structural protein 
L7Ae. Unlike the archetypical kink-turn, kink-loop structural motifs contain a terminal stem loop 
with four to seven nucleotides which is incapable of forming both Watson-Crick base pairs and 
A-minor interactions, but which is flanked by two sheared A-G base pairs and can extrude a 
nucleotide in the loop similar to kink-turn structures [28]. 
H/ACA Protein Core 
H/ACA snoRNAs associate with four eukaryotic highly conserved proteins: Cbf5 (dyskerin in 
humans, and NAP57 in mice), Gar1, Nhp2 (L7Ae in archaea), and Nop10 [14, 22-23, 29]. 
Depletion studies of all four proteins have shown that all H/ACA proteins with the exception of 
Gar1 are essential for complex viability and stability [29-32].  
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Cbf5 is the catalytic enzyme of the complex, sharing significant sequence similarity with 
the E. coli pseudouridine synthase TruB [33-34]. Depletion of Cbf5 results in the loss of 
pseudouridine formation and in the decrease of H/ACA snoRNP accumulation [14]. Cbf5 and 
TruB share a large N-terminal catalytic domain and a C-terminal PUA domain [35-36]. The N-
terminal catalytic domain can be divided into two subdomains, D1 and D2, forming the catalytic 
pocket between them [24]. Within the catalytic pocket lies the universally conserved catalytic 
aspartate and two highly conserved polar residues [13, 21, 37]. Cbf5 interacts with two of the 
three H/ACA structural proteins (Nop10 and Gar1) in addition to the snoRNA. Cbf5’s D1 and D2 
subdomains make several contacts with structural protein Nop10 which presumably helps to 
stabilize Cbf5 in its catalytically active conformation, and which contributes to the structural 
stability of H/ACA snoRNPs [35]. Cbf5’s D2 subdomain also makes critical contacts with 
structural protein Gar1 which has been proposed to assist in the loading and turnover of substrate 
rRNA [25].  
Nop10 is a small two-domain protein consisting of an N-terminal β-domain and a C-
terminal α-helix domain [35]. The two domains of Nop10 are connected by a highly conserved, 
unstructured linker region. On its own, Nop10 is a disordered protein, however Nop10 becomes 
highly structured upon binding to Cbf5’s catalytic domain [15]. 
Eukaryotic H/ACA structural protein, Nhp2, has a similar structure to its archaeal 
homolog L7Ae and to its eukaryotic homolog snu13p/15.5K which are monomeric proteins 
folding into a single globular domain [38]. Accordingly, Nhp2 is a member of the L7Ae/L30 
RNA-binding protein family. These proteins specifically recognize kink-turn RNA structural 
motifs. However, Nhp2 is the only member of this protein family which does not interact with 
kink-turn and kink-loop structures, binding double-stranded RNA instead [39-40]. In contrast, 
Nhp2’s archaeal homolog L7Ae can interact with kink-turn and kink-loop structural motifs with 
high specificity. The Maxwell group demonstrated that replacement of L7Ae’s signature residues, 
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responsible for kink-turn recognition, with those of Nhp2 resulted in the loss of L7Ae kink-loop 
binding and a reduction in L7Ae kink-turn binding [40].   
H/ACA structural protein Gar1 is a member of the reductase, isomerase and elongation 
factor fold superfamily, folding into the characteristic six-stranded β-barrel structure. Gar1 
interacts with the catalytic domain of Cbf5 without having direct contacts to the H/ACA RNA. 
Gar1 has been suggested to play a role in the recruitment and release of substrate rRNA through 
its interaction with Cbf5’s thumb loop [25]. 
I.V  Assembly of H/ACA Small Nucleolar Ribonucleoproteins 
Stable accumulation of mature eukaryotic H/ACA snoRNPs requires the co-transcriptional 
assembly of H/ACA snoRNAs with H/ACA snoRNP core proteins with the help of additional 
assembly factors [41]. Together the assembly factors and the core proteins prevent the 
degradation of the snoRNA and promote the stepwise assembly of the mature H/ACA snoRNP 
complex. Within eukaryotic organisms, two assembly factors, Shq1 and Naf1, appear to be 
required for the correct assembly and accumulation of mature H/ACA snoRNPs. Both Shq1 and 
Naf1 interact with Cbf5 during assembly.  
Shq1 Assembly Factor 
Shq1 is a modular protein consisting of two independent domains, an N-terminal HSP20-like 
domain and a C-terminal Shq1 domain. The heat shock protein (HSP) 20-like domain of Shq1 is 
also found in numerous co-chaperones for HSP90. Therefore, Shq1 may either act as an Hsp90-
independent snoRNP-specific chaperone, or it may specifically recruit Cbf5 to the Hsp90 
chaperone system [42-43]. Shq1 is involved in the initial steps of H/ACA biogenesis interacting 
only with free Cbf5 prior to Naf1 association [44]. Shq1 appears to function as a Cbf5 chaperone 
stabilizing free Cbf5 and potentially assisting in the folding of the protein while following Cbf5 
from synthesis to its association with Nop10, Nhp2, and Naf1 [44].  
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Naf1 Assembly Factor 
The structure of Naf1 most closely resembles that of the reductase, isomerase and elongation 
factor folds superfamily sharing the six-stranded β-barrel secondary structure common among 
members of this family [45]. H/ACA structural protein Gar1 is also a member of this superfamily, 
containing the same characteristic secondary and tertiary structure. Naf1 also shares a conserved 
Cbf5 binding surface with Gar1 [45]. The structural similarities found between Naf1 and Gar1 are 
the only commonalities shared between the two proteins as their functional roles are very 
different. While Gar1 is essential for H/ACA snoRNP function, it is the only H/ACA protein not 
required in the biogenesis of H/ACA snoRNPs [46]. Naf1 however is essential for the 
accumulation of H/ACA snoRNAs and the stable association of Cbf5 with the H/ACA snoRNA 
transcripts, but has no role in H/ACA snoRNP function [47-48]. Based on this information, it has 
been suggested that Naf1 and Gar1 each interact with Cbf5 in a mutually exclusive manner where 
Naf1 associates with the D2 subdomain of Cbf5 similarly to Gar1 [47]. Subsequently, the Naf1-
Cbf5 complex is co-transcriptionally recruited to the H/ACA snoRNA transcript along with 
H/ACA structural proteins Nop10 and Nhp2 [47]. Finally, Naf1 is replaced by Gar1 forming a 
mature H/ACA snoRNP complex.   
I.VI  Substrate binding by H/ACA Small Nucleolar Ribonucleoproteins  
Substrate RNA containing the target uridine for modification is recognized by 
complementary sequences found within the H/ACA snoRNA’s internal pseudouridylation pocket, 
forming two substrate-guide helices [49-50]. The lower and upper stems of the H/ACA snoRNA 
are anchored by Cbf5’s PUA domain and L7Ae/Nhp2 placing the substrate-guide RNA complex 
near the catalytic cleft of Cbf5 [51]. Correct placement of the substrate RNA within the catalytic 
cleft of Cbf5 is also highly dependent on the presence of H/ACA structural protein Nhp2 
(archaeal L7Ae). Gar1 association with Cbf5 influences the conformation of Cbf5’s thumb loop 
which is critical for substrate loading and release [25]. The thumb loop of Cbf5 pinches the 
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substrate RNA at the active site ensuring the correct placement of the target uridine within the 
catalytic cleft of Cbf5 [25]. Once in contact with Cbf5, the substrate RNA makes extensive 
interactions with Cbf5’s polar catalytic cleft [25].  
I.VII Functional Importance of H/ACA Small Nucleolar Ribonucleoproteins   
Ribosome Biogenesis 
During ribosome biogenesis, H/ACA snoRNAs have two primary functions, pre-rRNA 
modification through pseudouridylation and rRNA processing. As previously discussed, the 
isomerisation of specific uridine residues to pseudouridines has a profound effect on the chemical 
and structural properties of mature rRNA. While the majority of H/ACA snoRNAs function in the 
formation of pseudouridines, a few H/ACA snoRNAs function in rRNA processing through the 
nucleolytic cleavage of rRNA. To date, two H/ACA snoRNAs have been shown to be involved in 
rRNA processing, snR30 and snR10. 
 H/ACA snoRNA snR30 is essential for the correct processing and accumulation of 18S 
rRNA, and is required for correct cleavage of the 35S pre-rRNA transcript at the A0, A1 and A2 
cleavage sites [52]. H/ACA snoRNA snR30 shares the common consensus hairpin-hinge-hairpin 
secondary structure with all H/ACA snoRNAs [53]. Interestingly all snR30 snoRNAs carry an 
additional internal hairpin upstream of the 3’-terminal hairpin [53]. Deletion analysis has 
demonstrated that this internal hairpin and the 5’-terminal hairpin are not essential for cell 
viability nor do they contain any functionally pertinent elements [53]. Similar analysis of the 3’-
terminal hairpin revealed that this structural element of snR30 carries all of the functionally 
important elements needed for cell viability [53]. Contained within the lower region of the 
internal loop of the 3’-terminal hairpin are two highly conserved sequence motifs, m1 
(AUAUUCCUA) and m2 (AAACCAU), which form transient Watson-Crick interactions with 
two short internal sequence elements within the 18S rRNA [53-54]. Hence, snR30s m1 and m2 
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structural motifs are 18S rRNA recognition elements interacting with two distantly located 18S 
rRNA internal sequence elements which are folded together by a stem-loop structure conserved in 
all 18S rRNAs [53-54]. This Watson-Crick interaction between snR30 and the 18S rRNA is 
essential for 18S rRNA production and cell viability. Alteration or complete deletion of either the 
m1 or m2 motif results in different rRNA processing pathways and in certain cases loss of cell 
viability [53]. The terminal stem-loop region of snR30’s 3’-terminal hairpin functions as a 
snoRNP protein binding site which targets essential snR30-asscoiated processing factors to the 
pre-rRNA transcript [54]. 
 H/ACA snoRNA snR10 also plays an important role in yeast rRNA processing and the 
accumulation of 18S rRNA. Unlike snR30, snR10 is not essential for cell viability as deletion of 
snR10 results in modest reductions in cellular growth rates and a slight cold-sensitive phenotype 
[55]. In addition to its role in rRNA processing, snR10 is also responsible for the 
pseudouridylation of uridine 2923 in the PTC region of the 25S rRNA [26]. Like all other H/ACA 
snoRNAs, snR10 folds into the hairpin-hinge-hairpin consensus secondary structure with the 
functional elements required for rRNA processing located exclusively in the 5’-terminal hairpin 
and the functional elements required for pseudouridylation mapped to the 3’-terminal hairpin 
[56]. The rRNA processing domain and pseudouridylation domain of snR10 function 
cooperatively in which a C-insertion mutation within the pseudouridylation pocket affects not 
only pseudouridylation but also impairs 18S rRNA processing [56]. The dual effect of such a 
mutation may be suggestive of snR10’s role as a factor bringing together or stabilizing the 
precursor forms of the ribosomal subunits [56]. 
Pre-mRNA Splicing   
The protein coding sequence of eukaryotic genes is disrupted by a series of interspersed non-
coding sequences known as introns. Following transcription, the intervening sequences are 
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removed during mRNA splicing. Splicing is performed by spliceosomes, large RNP complexes 
consisting of several small nuclear RNP (snRNP) subunits. There are five snRNP subunits in 
total, each defined by a small nuclear RNA (snRNA) (U1, U2, U4, U5 and U6) in complex with 
several protein subunits [57]. The individual snRNP subunits assemble on a pre-mRNA transcript 
forming the spliceosome with portions of the spliceosome entering and leaving as the splicing 
reaction proceeds [57]. Throughout the splicing reaction important regions of the pre-mRNA are 
recognized by the snRNA through the formation of base-pairing between the snRNA and the pre-
mRNA intron consensus sequences.  
All five of the spliceosomal snRNAs are post-transcriptionally modified by 
pseudouridylation and 2’-O-methylation [58]. Again similar to rRNA, all modifications cluster in 
functionally important regions of the spliceosome and are involved in numerous intermolecular 
interactions. Of the five spliceosomal snRNAs, U2 is the most extensively modified snRNA 
containing ten 2’-O-methylated residues and thirteen pseudouridines [59]. The single stranded 
branch site recognition region of U2 snRNA contains six uridines which are all converted to 
pseudouridines [60]. One particular pseudouridine within the branch site recognition region is 
essential for the bulging out of the branch point adenosine nucleotide in the first step of RNA 
splicing [61-62]. The presence of this pseudouridine enhances the formation of the 
phosphodiester bonds during catalysis [63]. All of the pseudouridylation modifications of U2 
snRNA are required for snRNP assembly and RNA splicing [64-65]. The presence of 
pseudouridines within the spliceosomal RNA appears to provide stabilization to the snRNP 
complex during the formation of the bulge at the branch point adenosine [64]. 
Telomere Maintenance 
One vital step of the eukaryotic cell cycle is the duplication of chromosomes. The DNA 
polymerase however cannot completely replicate the chromosome ends resulting in incomplete 
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replication [57]. To prevent chromosome deterioration and the loss of critical genetic information 
during mitosis, regions of repetitive DNA repeats known as telomeres are found at the end of 
each chromosome [57]. Telomeres protect chromosomal ends by providing a type of disposable 
buffer which is deteriorated during cellular division [57]. To ensure that the telomere ends of 
chromosomes are never completely lost, telomeres of cells in the germ line and of some stem 
cells are maintained and replenished by telomerase reverse transcriptase [57].    
Telomerase is a ribonucleoprotein particle consisting of telomerase RNA (TERC) and 
telomerase reverse transcriptase. The telomerase RNA contains the template for the synthesis of 
the telomeric repeats. While the size and sequence composition of telomerase RNA varies 
significantly among different species, telomerase RNAs share a common core secondary structure 
[66]. All telomerase RNAs share a 5’ template boundary element and a large loop which contains 
the core pseudoknot domain, the template and a loop-closing helical region [66]. In addition to 
the common core secondary structure, the 3’ end of vertebrate telomerase RNA folds into a 
characteristic H/ACA snoRNA structure [67]. This 3’ H/ACA domain found within telomerase 
RNA contains both the H and ACA consensus sequences found in other H/ACA snoRNAs [67]. 
The H and ACA consensus sequences are important for the stability of telomerase RNA as 
alteration of either sequence results in reduced levels of telomerase RNA [67]. The telomerase 
RNA H/ACA domain also associates with H/ACA core proteins Cbf5, Nop10, and Nhp2 
suggesting that H/ACA core proteins interact with the H/ACA domain of telomerase RNA in a 
similar manner as they assemble with H/ACA snoRNA [67-68]. A model explaining the role of 
H/ACA RNP proteins in 3’TERC formation and mature TERC accumulation was proposed by the 
Henry group: presumably the 3’ H/ACA domain of telomerase RNA acts as a barrier for 3’→5’ 
exonuculease, stopping its advancement during telomerase RNA maturation [30]. This in turn 
would prevent the turnover of telomerase RNA and allow for the development and maturation of 
the telomerase RNA 3’-end [30]. 
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I.VIII Dyskeratosis Congenita 
The rare inherited disease Dyskeratosis congenita (DC) is a clinically and genetically 
heterogeneous disease affecting multiple systems. DC patients typically share characteristic 
hyperpigmentation along the neck, shoulders, and face in addition to developing nail dystrophy 
and mucosal leukoplakia [69]. Bone marrow failure arises in the vast majority of DC patients 
frequently leading to death through increased susceptibility to infection and haemorrhaging [69-
70]. DC has three known inherited forms: X-linked recessive, autosomal recessive and autosomal 
dominant [69].  
 The X-linked recessive form of DC is the most common and severe form of DC [69-71]. 
The X-linked recessive form of DC is primarily caused by missense mutations in the H/ACA 
catalytic protein dyskerin (of which Cbf5 is the yeast homolog) [72-73]. Dyskerin DC 
substitutions are primarily found within the PUA domain with additional substitutions localized 
to the N-terminal extension, resulting in a spatial cluster along one side of the PUA domain [15, 
24, 71]. The autosomal recessive form of DC is the most genetically heterogeneous form, closely 
resembling X-linked recessive DC with the onset of symptoms occurring in the later stages of life 
[74]. Autosomal recessive DC has been linked to mutations in the genes of the H/ACA structural 
proteins Nhp2 and Nop10 [74-76]. Autosomal dominant DC is the result of point mutations 
within the RNA component of the telomerase. In general, autosomal dominant patients exhibit 
milder forms of DC, often possessing asymptomatic carriers [77-78]. Autosomal dominant DC is 
a prime example of disease anticipation, where the severity of the TERC mutations increases in 
later generations with the onset of symptoms and death occurring at earlier ages with each 
generation [78]. 
 While research continues to bring forth increasing information on the molecular cause(s) 
and effects of DC, a comprehensive understanding of the disease is still lacking, leaving many 
unanswered questions open for discussion. One particular question that remains is whether DC is 
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a disease of ribosome biogenesis or telomere maintenance. DC patients are often diagnosed with 
critically short telomeres suggesting that DC is in fact a disease of telomerase [77]. A mouse 
model of DC based on the reduction of Dkc1 expression displayed no detectable changes in 
telomere length in early generations of the hypomorphic mice [79]. However, a marked reduction 
in pseudouridine formation within the 28S and 18S rRNA was observed in addition to an 
increased occurrence of immature pre-rRNA intermediates [79]. This would suggest that DC 
affects ribosome biogenesis. The fact that NAP57 interacts with both TERC and H/ACA snoRNA 
raises the possibility that DC may be a disease of ribosome biogenesis as well as telomere 
maintenance.  
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II 
H/ACA snoRNP Structural Protein Nhp2 
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II.I  Introduction 
Nhp2, a Member of the L30 Protein Family 
S. cerevisiae H/ACA snoRNP structural protein Nhp2 was first identified as a high mobility 
group (HMG)-like nuclear protein, sharing similar physical and chemical properties with other 
HMG proteins [80]. However, sequence analysis later showed that Nhp2 shared no sequence 
similarities to other known HMG proteins, but did in fact share significant sequence similarity 
with the RNA binding protein family L7Ae/L30 [81]. Members of the L7Ae/L30 protein family 
specifically recognize kink-turn structural RNA motifs.  
Members of the L7Ae/L30 protein family contain a highly conserved RNA-binding 
region which directly interacts with the kink-turn motif. Primary sequence analysis of the 
L7Ae/L30 protein family revealed five signature amino acid residues which are variable and 
unique to each member, appearing to confer RNA recognition specificity exclusive to each 
member [40]. These five signature amino acid residues flank the RNA-binding region. Four of the 
five residues are found within the highly conserved C-terminal loop 9 region, positioning them in 
close vicinity to the RNA kink-turn motif [40]. The L7Ae/L30 protein family contains two 
members, archaeal protein L7Ae, and eukaryotic protein Nhp2, that have unique properties. L7Ae 
is the only protein which can interact with both kink-turn and kink-loop structures, while Nhp2 is 
the only member which has been reported not to interact with kink-turn and kink-loop structures 
[39-40]. Interestingly, both are structural proteins in H/ACA snoRNP complexes, with L7Ae 
replacing Nhp2 in the archaeal system. Replacement of L7Ae’s signature RNA recognition 
residues flanking the N- and C-terminal sides of the protein’s RNA recognition region with those 
of Nhp2 resulted in loss of L7Ae kink-loop binding and a reduction in L7Ae kink-turn binding, 
further supporting the idea that Nhp2 differs significantly from its homologues [40]. 
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Nhp2 is a Eukaryotic H/ACA snoRNP Structural Protein  
During early characterizations of H/ACA snoRNPs, Nhp2 was shown to be a component of 
eukaryotic H/ACA snoRNPs. Nhp2 has the ability to associate specifically with known H/ACA 
snoRNAs and was observed to be essential for H/ACA snoRNP function [29]. The Henry group 
demonstrated that purified S. cerevisiae Nhp2p could directly interact with in vitro transcribed 
H/ACA snoRNA, snR36, with a high affinity (KD ~ 4 nM) using electrophoretic mobility shift 
assays (EMSA). Interestingly, multiple shifted bands were observed, suggesting that Nhp2 has 
more than one binding site [39]. This observation is in good agreement with the hypothesis that 
two sets of H/ACA core proteins associate with both hairpin structures of bipartite snoRNA in 
eukaryotes. However, most of what is currently known about eukaryotic H/ACA snoRNPs and 
Nhp2 comes from the work done on the archaeal H/ACA structural protein L7Ae (Fig. 5). 
Structural analysis and interaction studies involving L7Ae and Nhp2 strongly suggest that both 
proteins share a common function within H/ACA snoRNPs as similar protein-protein and protein-
RNA interactions have been documented [24, 28, 39, 68, 82-83]. 
L7Ae is a monomeric protein which folds into a single globular domain [38]. Alternating 
α helices and β strands form an α-β-α sandwich structure, in which the central β-sheets contain 
three anti-parallel strands and one parallel strand while three α-helices pack along one side of the 
β-sheet and two other α-helices pack along the other side of the β-sheet [38]. Additionally, the 
recently determined structure of C. parvum Nhp2 shows the same folds (Fig. 5) [84]. 
L7Ae contains a significant number of positively charged residues. Electrostatic potential 
calculations have shown a positively charged region near the surface of the protein involving the 
solvent accessible regions of the α2 helix, the β1 strand, and the loops connecting α1-β1, α2-β2, 
α3-β3, and β4-α5 [38]. Structural analysis of L7Ae-RNA complexes show L7Ae interacting with 
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the RNA primarily through the α2 helix, β1 strand, and the β1-α2, β2-α3, and α4-β4 loops [28, 
83].  
 
Figure 5: Sequence alignment and structural comparison of H/ACA structural proteins Nhp2 and 
L7Ae, and location of Dyskeratosis congenita substitutions within Nhp2. A. Multiple sequence 
alignment of eukaryotic Nhp2 and archaeal L7Ae. Of the five aligned sequences three are eukaryotic: 
Saccharomyces cerevisiae (ScerNhp2), Homo sapiens (HsapNhp2), and Cryptosporidium parvum 
(CparNhp2), and two are archaeal: Methanocaldococcus jannaschii (MjanL7Ae) and Pyrococcus furiosus 
(PfurL7Ae). The secondary structure elements are shown above the sequences, with α-helices depicted as 
rectangles and β-strands as arrows. The secondary structural elements were determined from the 
Pyrococcus furiosus H/ACA snoRNP structure [24]. Completely conserved residues among the aligned 
sequences are shaded in black, and residues with at least 60% conservation are shown in grey. Two 
positions in Nhp2 which are changed in Dyskeratosis congenita patients are outlined by red boxes. The 
alignment was prepared using ClustalW (EMBL-EBI)  and Gene Doc (Dr. Nicholas Hugh). B. 
Superposition of C. parvum Nhp2 (blue, PDB 2AIF [84]) and M. jannaschii L7Ae (green, PDB 1XBI [85]) 
crystal structures. The structural alignment was made with Pymol Molecular Visualization Evaluation 
Product (Delano Scientific LLC). C. The crystal structure of C. parvum Nhp2 (blue, PDB 2AIF [84]) was 
used to model the S. cerevisiae DC substitution V122M (V126M in humans) and F146H (Y139H in 
humans) isolated in autosomal recessive DC patients. 
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The association of L7Ae with the kink-loop RNA motif in archaeal H/ACA snRNA 
anchors the upper stem of the guide RNA assisting in the correct placement of the 
pseudouridylation pocket within the catalytic domain of Cbf5 [24, 86]. The absence of L7Ae 
binding results in a dramatic shift in the location of the guide RNA relative to the catalytic 
domain of Cbf5, subsequently placing the target uridine approximately 11 Å away from the 
catalytic aspartate [51, 86].  
 L7Ae interacts with the characteristic protruding uridine residue and the tandem sheared 
G-A base pairs of the kink-loop within the upper hairpin of the H/ACA snoRNAs. Mutation of 
either the protruding uridine residue or of the G-A residues dramatically reduces or abolishes 
L7Ae binding [87]. L7Ae backbone atoms are predominantly responsible for the recognition of 
the protruding uridine residue, while side chain atoms are primarily responsible for the 
recognition of the tandem sheared G-A base pairs [28]. Interestingly, several basic residues 
making up the RNA binding surface of L7Ae are conserved in Nhp2 [24]. 
 In addition to binding the H/ACA guide RNA, L7Ae makes several interactions with 
H/ACA structural protein Nop10, binding within the trough of Nop10 between the N-terminal 
zinc-ribbon and a C-terminal α helix [24]. The α3 helix of L7Ae contacts the α1 helix of Nop10 at 
a right angle through a salt bridge and three Nop10 aromatic rings stacked above a hydrophobic 
region of L7Ae [24]. Additionally, L7Ae’s β2-α3 loop interacts with the linker region of Nop10 
through van der Waals interactions and hydrogen bonding [24]. Residues within both L7Ae and 
Nop10 involved in this interface are conserved in eukaryotic Nhp2 and Nop10, strongly 
suggesting that Nhp2 associates with Nop10 in a similar manner as L7Ae [24]. Supporting this 
hypothesis is the observation that association of Nhp2 to the H/ACA snoRNP complex is 
dependent on the formation of a Nop10-Cbf5 complex [68, 82].  
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Dyskeratosis Congenita and Nhp2 
As previously mentioned, DC has been linked to four known genes, including NHP2. Mutations 
within NHP2 result in the autosomal recessive form of DC, the most genetically heterogeneous 
form of this inherited bone-marrow failure syndrome [76]. To date three Dyskeratosis congenita 
mutations have been indentified in Nhp2, V126M, Y139H, and X (stop codon) 154R [76].   
 Valine 126 is involved in the core packing of Nhp2 with Nop10, as it is positioned 
directly above the α helix which interacts with Nop10 [75]. It has been shown that mutation of 
this residue obstructs core packing, destabilizing Nhp2’s interaction with Nop10. Tyrosine 139 is 
also located in the interior of the Nhp2 structure based on a model of the Nhp2 structure derived 
from the L7Ae structure suggesting an important role for Nhp2 protein structure and stability 
[75]. While tyrosine 139 does not appear to directly contact Nop10, mutation of this residue 
interferes with Nop10 association as Nhp2 stability may be compromised [75]. The Dragon group 
observed that Nhp2 containing V126M and Y139H mutations were unable to form the H/ACA 
protein tetramer complex, strongly suggesting that Nhp2’s structural integrity/stability had been 
compromised [75]. However, the effects of these mutations on RNA binding by Nhp2 have not 
been studied. 
 The third mutation X154R, results in a 51 amino acid extension of Nhp2’s C-terminus, as 
the wild-type stop codon of Nhp2 is mutated to an arginine residue [76]. In vitro studies have 
shown that H/ACA protein tetramer formation is not impaired by the X154R mutation, however 
the possibility of such a mutation affecting RNP association cannot be ruled out as it might affect 
RNA binding [75].  
II.II Objective 
The protein Nhp2 is part of the eukaryotic H/ACA small nucleolar ribonucleoprotein complex 
which introduces pseudouridine modifications in many cellular RNAs. Eukaryotic H/ACA 
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structural protein Nhp2 is a member of the L7Ae/L30 RNA-binding protein family. Members of 
the L7Ae/L30 protein family specifically recognize kink-turn RNA structural motifs. Nhp2 is 
however the only member which does not interact with kink-turn structures. Nhp2’s archaeal 
homolog L7Ae can interact with kink-turn structural motifs with high specificity. Mutations 
within three of the four H/ACA core proteins, Cbf5, Nop10 and Nhp2 have been linked to the 
rare inherited disease DC. To date three DC substitutions have been identified in Nhp2: V126M, 
Y139H, and X154R. These findings raise the questions how Nhp2 recognizes and interacts with 
H/ACA snoRNAs and what effects the DC substitutions in Nhp2 have on RNA recognition. 
 To answer these questions, it was my objective to purify S. cerevisiae Nhp2 and to in 
vitro transcribe an H/ACA snoRNA, snR34. Furthermore, it was my aim to create and purify two 
Nhp2 variants, V122M and F146H, corresponding to mutations in human Nhp2 found in DC 
patients. By using [
32
P]-labelled RNA in EMSA analysis, we can detect and quantify the 
interaction of Nhp2 with H/ACA snoRNA. A initial truncation of snR34 was transcribe to begin 
the identification of the minimal binding site of Nhp2 on snR34. In addition, the initial 
characterization of the binding affinity, stoichiometry and thermodynamics of the Nhp2-RNA 
interaction was analyzed by isothermal titration calorimetry (ITC).    
II.III Materials and Methods 
Recombinant expression of Nhp2 
Nhp2 was recombinantly expressed in E. coli BL21 (DE3) Rosetta cells (VWR). 100 mL of LB 
medium (1% (w/v) tryptone, 0.5% (w/v) yeast extract, and 1% (w/v) NaCl, pH 7.0) with 0.1 
mg/mL kanamycin was inoculated with BL21 (DE3) Rosetta cells containing pET28a-ScNhp2 
and grown overnight at 37 
o
C. The cells were pelleted and resuspended in 50 mL of fresh 
kanamycin-containing LB medium. 2 L of LB-kanamycin medium was inoculated to an optical 
density of approximately 0.1 (OD600). Cultures were incubated at 37 
o
C while shaking with cell 
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growth monitored at 600 nm. Recombinant protein expression was induced at an optical density 
of 0.6 OD600 by adding IPTG to a final concentration of 1 mM. The cell density was recorded for 
three additional hours with cell samples of 1 OD600 being taken at times 0 hr, 0.5 hr, 1.0 hr, 2.0 hr, 
and 3.0 hr after induction. After 3 hr cell cultures were pelleted by centrifugation at 5000 xg and 
shock frozen with liquid nitrogen and stored at -80 
o
C. Cell samples were suspended in 80 µL of 
cell lysis buffer (0.1 M Tris-HCl pH 8.5 containing 8 M urea) and boiled for 5 minutes at 95 
o
C to 
open cells. Cell samples were analyzed by SDS-PAGE and visualized using Coomassie staining.  
Site directed mutagenesis of Nhp2 
DC point mutation V122M and F146H were introduced into pET28a-ScNhp2 wild-type plasmid 
DNA by site directed quick change mutagenesis using the following primer pairs:  
Nhp2 V122M F: GACCTACCTCAATGGTCTTTATCGTCCCGGGTAGCAATAAG  
            R: CTTATTGCTACCCGGGACGATAAAGACCATTGAGGTAGGTC 
 
Nhp2 F146H F: GAAGAATACAAGGAATCTCACAACGAAGTTGTCAAAGAAGTTCAAGC  
                      R: GCTTGAACTTCTTTGACAACTTCGTTGTGAGATTCCTTGTATTCTTC  
Plasmid DNA was purified with an EZ-10 Spin Column PCR Products Purification Kit (Bio 
Basic Inc.), following the manufacturer’s instructions. Mutagenesis reactions were carried out in 
25 µL volumes with final component concentrations as follows: 1x Pfu buffer with MgSO4, 0.4 
mM dNTPs, 0.4 µM primers, 0.12 U/µL Pfu DNA polymerase (Fermentas), and 40 ng/µL 
pET28a-ScNhp2 wild-type plasmid DNA. Amplification parameters included an initial 
denaturation at 95 
o
C for 5 min followed by 18 cycles of denaturation at 95 
o
C for 45 s, annealing 
at 45 
o
C for 60 s, extension at 68 
o
C for 900 s, and a final extension at 68 
o
C for 15 min. The 
mutagenesis product was subsequently incubated with 1µL of DpnI (Fermentas) overnight at 37 
o
C. DpnI was inactivated at 65 
o
C for 10 min. 5 µL samples of the mutagenesis reaction were 
taken prior to amplification, following the first amplification cycle, after mutagenesis, and after 
 26 
 
DpnI treatment for analysis by agarose gel electrophoresis. Mutagenesis products were analyzed 
on a 1% agarose gel at 110 V for 1hr and visualized by ethidium bromide staining [88].  
 pET28a-ScNhp2 V122M and pET28a-ScNhp2 F146H were transformed into high-
efficiency competent E. coli DH5α cells (NEB). Transformation mixtures were plated on LB agar 
containing 0.1 mg/mL kanamycin. Plates were incubated overnight at 37 °C. E. coli colonies 
were transferred into 5 mL of LB containing 0.1 mg/mL kanamycin and grown overnight at 37 
o
C. Plasmid DNA from the resulting cultures was isolated using an EZ-10 Spin Column Plasmid 
DNA Miniprep Kit (Bio Basic Inc.), following the manufacturer’s instructions. pET28a-SNhp2 
V122M plasmid DNA was isolated and screened for positive mutagenesis through restriction 
digestion. 20 µL restriction digestions of pET28a-SNhp2 V122M (SmaI) was incubated at 30 
o
C 
for 2 hr with final component concentrations of:  1x Tango Buffer (Fermentas), ~2 µg pET28a-
SNhp2 V122M plasmid DNA, and 2 U/µL SmaI restriction enzyme (Fermentas). Restricted 
colonies were analyzed on a 1% agarose gel at 110 V for 1 hr and visualized with ethidium 
bromide staining [88]. pET28a-SNhp2 F146H were sent directly for sequencing for mutagenesis 
confirmation. pET28a-SNhp2 V122M clones appearing to be positive were then sent to Macrogen 
Inc. for sequencing. 
Purification of H/ACA protein Nhp2 
Recombinantly expressed, histidine (His)-tagged Nhp2 was initially purified by nickel-sepharose 
affinity chromatography. E. coli BL21 (DE3) Rosetta cells containing His-tagged Nhp2 were 
resuspended in cell lysis buffer (1 mL/g of cells) containing: 50 mM Tris-HCl pH 8.0, 400 mM 
KCl, 0.1 mM phenylmethylsulfonyl fluoride (PMSF), 5 mM β-mercaptoethanol, 5 % glycerol, 30 
mM imidazole. 1 mg/ml lysozyme was added to the resuspended cells followed by incubation for 
30 min. Next 12.5 mg/g of cells sodium deoxycholate was added to the resuspended cells, and the 
suspension was incubated further for 20 min. Cells were opened by sonication for 1 min with 20 s 
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breaks, repeated five times using an intensity level of 6, and duty cycle of 60%. Cell debris was 
pelleted at 30 000 x g for 30 min at 4 
o
C. The cleared cell lysate was loaded onto a 5 mL Ni-
Sepharose column (GE Healthcare) at a flow rate of 0.5 ml/min using a BioLogic LP 
chromatography system (BioRad) while the presence of protein was observed through absorbance 
measurements at 280 nm. The column was washed at a flow rate of 1.5 mL/min with Buffer A, 
comprised of: 50 mM Tris-HCl pH 8.0, 400 mM KCl, 0.1 mM phenylmethylsulfonyl fluoride 
(PMSF), 5 mM β-mercaptoethanol, 5 % glycerol, and 30 mM imidazole. His-tagged Nhp2 was 
eluted using a gradient in which the concentration of imidazole was increased at a rate of 6 
mM/mL to a final concentration of 500 mM at a flow rate of 1 mL/min. Fractions of 1 mL/min 
were collected throughout the purification. Fractions were analyzed by 15% SDS-PAGE and 
visualized using Coomassie staining [88]. Fractions containing His-tagged Nhp2 were 
concentrated by ultrafiltration in Vivaspin MWCO 10000 (VWR) and re-buffered 1:100 in 
cation exchange low salt buffer (20 mM HEPES-KOH pH 8.0, 150 mM KCl, 0.5 mM EDTA, 1.5 
mM MgCl2, 2% glycerol, 5 mM β-mercaptoethanol).  
 His-tagged Nhp2 was further purified by cation exchange chromatography. His-tagged 
Nhp2 was loaded onto a 100 mL SP-sepharose cation exchange column (GE Healthcare) at a flow 
rate of 0.5 mL/min in the presence of low salt buffer using a BioLogic DuoFlow chromatography 
system (BioRad) while the protein absorbance at 280 nm was recorded. The column was washed 
at a flow rate of 4.0 mL/min with 60 mL of low salt buffer. His-tagged Nhp2 was eluted using a 
gradient in which the concentration of salt was increased at a rate of 20 mM/mL to a final 
concentration of 1000 mM at a flow rate of 4.0 mL/min. Fractions of 4 mL/min were collected 
throughout the purification. Fractions were analyzed by SDS-PAGE and visualized using 
Coomassie staining [88]. Fractions containing His-tagged Nhp2 were concentrated by 
ultrafiltration using a Vivaspin MWCO 10000 (VWR) and were subsequently shock frozen in 
liquid nitrogen and stored at -80 °C. The protein concentration was determined using absorbance 
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readings at 210 nm and an extinction coefficient of 20.5 mL mg
-1 
cm
-1
 as well as by quantification 
of SDS-PAGE with the software Image J 1.41 (Apache Software Foundation). 
PCR amplifications of DNA template for H/ACA snoRNA  
The template DNA for wild-type and truncated H/ACA snoRNA snR34 was amplified from 
pTZ19r-snR34 plasmid DNA by polymerase chain reaction (PCR) using the following primer 
pairs:  
snR34 wt F: AGCTATGACCATGATTACGCC  
snR34 wt R: mUmAATGTAGACTTTCTTCGACATCCC 
snR34 T  F: AGCTATGACCATGATTACGCC  
snR34 T  R: mUmCTTGTTTGAAATACTGGCAATTAACTACTG  
PCR reactions were carried out in 50 µL volumes with final concentrations as follows: 1x Pfu 
buffer with MgSO4, 200 µM dNTPs, 0.5 µM of each primer, 0.02 U/µL Pfu DNA polymerase, 
and 40 ng/µL pTZ19r-snR34 plasmid DNA. PCR cycle parameters included an initial 
denaturation at 95 
o
C for 5 min followed by 6 cycles of denaturation at 95 
o
C for 30 s, touch-up 
annealing starting for 30 s at 45 
o
C with a 1 °C increase in each cycle, and extension at 72 °C for 
20 s, with an additional 30 cycles of denaturation at 95 
o
C for 30 s, annealing at 50 
o
C for 30 s, 
and extension at 72 
o
C for 20 s followed by a final extension at 72 
o
C for 11 min. PCR products 
were analyzed on a 2% agarose gel and visualized by ethidium bromide staining [88].  
In vitro transcription of H/ACA snoRNA 
Wild-type and truncated H/ACA snoRNA, snR34, was transcribed in vitro from the PCR 
amplified DNA template. Transcription reactions were carried out in 50 µL or 1.0 mL reaction 
volumes with final concentrations as follows: 1x transcription buffer (40 mM Tris-HCl pH 7.5, 15 
mM MgCl2, 2 mM spermidine, 10 mM NaCl), 10 mM DTT, 3 mM of each NTP, 5 mM GMP, 
0.01 U/µL inorganic pyrophosphatase (Sigma), 0.3 µM T7-RNA polymerase, 0.12 U/µL 
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RiboLock RNase Inhibitor (Fermentas) and 10% (v/v) template DNA. Transcriptions were 
performed at 37 °C for 4 hr. The DNA template was degraded through the addition of one crystal 
of DNase (Sigma) and further incubation for 1 hr at 37 °C. RNA products were analyzed by 11% 
urea-PAGE  at 300 V for 25 min and visualized by ethidium bromide staining [88].  
Purification of H/ACA snoRNA 
In vitro transcribed wild-type and truncated H/ACA snoRNA snR34 (1 mL) were purified with 
anion exchange chromatography using a Nucleobond AX500 gravity flow column (Machery-
Nagel). The column was equilibrated with 6 mL of equilibration buffer containing 100 mM Tris-
acetate pH 6.3, 10 mM MgCl2, and 15% (v/v) ethanol. The RNA (1 mL) was bound to the column 
after dilution with 13 mL of binding buffer composed of 200 mM KCl, 100 mM Tris-acetate pH 
6.3, 10 mM MgCl2, and 15% ethanol. The column was washed with 32 mL of washing buffer 
containing 100 mM Tris-acetate pH 6.3, 10 mM MgCl2, 300 mM KCl, and 15% (v/v) ethanol and 
eluted in 12 mL high salt elution buffer comprised of 100 mM Tris-acetate pH 6.3, 10 mM 
MgCl2, 1150 mM KCl, and 15% (v/v) ethanol. The RNA was subsequently precipitated with 
isopropanol for three days at -20 
o
C and re-suspended in 500 µL of ddH20. The purified RNA was 
analyzed by 11% urea-PAGE and visualized by ethidium bromide staining.  
Radiolabeling of H/ACA snoRNA 
Wild-type and truncated H/ACA snoRNA snR34 were radiolabeled with 
32
P. The H/ACA 
snoRNA was first dephosphorylated in a reaction volume of 20 µL containing: 0.2 µM RNA, 1x 
SAP buffer (Fermentas), and 1 U/µL SAP (Fermentas). The dephosphorylation reaction was 
performed at 37 
o
C for 30 min and stopped by heating at 65 
o
C for 15 min. H/ACA snoRNA was 
rephosphorylated in a reaction volume of 30 µL containing: 0.13 µM RNA, 1x SAP buffer 
(Fermentas), 5 mM DTT, 0.1 mM spermidine, 0.1 mM EDTA, 0.67 µM of [γ-32P]-ATP (20 µCi), 
10 U/µL T4 polynucleotide kinase (Fermentas). The phosphorylation reaction was carried out at 
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37 
o
C for 30 min and quenched by the addition 0.25 mM EDTA followed by heating at 75 
o
C for 
10 min. The labeled snoRNA was purified using Sephadex G-25 filtration spin column. 400 µL of 
Sephadex G-25 (Pharmacia) was added to a SigmaPrep spin column, the column was washed 
with 400 µL ddH2O following which labeled snoRNA was loaded and eluted from the column by 
centrifugation. The activity of labeled snoRNA was determined by liquid scintillation counting.  
Electrophoretic mobility shift assays 
Electrophoretic mobility shift assays (EMSA) were performed to analyze the interaction between 
Nhp2 and [
32
P]-radiolabeled H/ACA snoRNA. snR34 H/ACA snoRNA was incubated at 85 
o
C 
for 2 min and permitted to slowly cool to 30 
o
C to promote correct folding. RNA (2 nM) was 
titrated with increasing concentrations of Nhp2 (0 to 50 µM) in 15 µL reaction volumes in 1x 
binding buffer (30 mM Tris-HCl pH 7.4, 150 mM KCl, 2 mM MgCl2, 0.1% (v/v) Triton X-100, 1 
mM DTT, 20% (v/v) glycerol, 100 ng/µL BSA). Binding was allowed to occur for 30 min at 30 
o
C. Samples were analyzed on an 8% Tris-glycine native gel (8% Acrylamide/Bisacrylamide 19:1 
solution (Biobasic), 0.5x Tris-glycine buffer) in 0.5x Tris-glycine buffer (5 mM Tris pH 8.5 and 5 
mM glycine) for 18 hr at 100 V at 4 
o
C and visualized by autoradiography. By plotting the 
concentration of Nhp2 was versus the intensity of the shifted band (determined by ImageJ) in 
Prism GraphPad3, a KD for the interaction was extrapolated using the equation: y = 
Bmax*x/(KD+x), where Bmax is the maximal binding and KD is the concentration of protein 
required to reach half-maximal binding 
tRNA competition experiments 
tRNA competition experiments were performed to analyze the binding specificity of Nhp2 to a 
[
32
P]-radiolabeled H/ACA snoRNA using previously described EMSA conditions. 2 nM of snR34 
H/ACA snoRNA was incubated at 85 
o
C for 2 min and permitted to slowly cool to 30 
o
C to 
promote correct folding. The RNA was then incubated with Nhp2 wild-type (50 nM), Nhp2 
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F146H (30 µM), and Nhp2 V122M (30 µM) in the presence and absence of 10 µM unlabeled 
tRNA in 15 µL reaction volumes in 1x binding buffer. Binding was allowed to occur for 30 min 
at 30 
o
C. Samples were analyzed on an 8% Tris-glycine native gel in 0.5x Tris-glycine buffer for 
18 hr at 100 V at 4 
o
C and visualized by autoradiography.  
Isothermal titration calorimetry 
All isothermal titration calorimetry (ITC) experiments were performed at 30 
o
C on a VP ITC 
Microcalorimeter (Microcal). The cell volume was 1.7 mL, and the syringe volume was 300 µL. 
All solutions and samples were degassed prior to each experiment. Nhp2 was dialyzed in 2 L of 
ITC buffer (20mM HEPES-KOH pH 7.5, 150 mM KCl, and 15 mM MgCl2) for 48 hr. After 
dialysis, the ITC buffer was saved for the actual ITC experiments. snoRNA was diluted in ITC 
buffer to a concentration of 5 µM (snR34 wt) and 2.8 µM (snR34 truncated), then heated to 85 
o
C 
for 2 min and permitted to slowly cool to 30 
o
C to promote correct folding. The experimental 
parameters used in each ITC analysis can be found in Table 1. snR34 concentrations used were 
determined by the equation, c = K x Mtot x n, in which K is the association constant, n is the 
stoichiometry parameter, Mtot is the total biomolecule concentration within the cell, and c is a 
unitless constant which determines the shape of the resulting thermogram. For ideal K 
measurements, c should be between 5 – 500. By solving the equation for Mtot, a minimal 
concentration of RNA is estimated for the cell. To determine the concentration of protein needed 
for the syringe, the equation Xtot x V/V = n x Mtot x 1.5, was used where Xtot is the total 
concentration of protein in the syringe, V is the total volume of protein to be injected, and V is 
the total volume of the cell. The reference power determines the value to which the baseline will 
settle once equilibrium has been reached within the cell. As it was initially hypothesized that the 
system would be largely exothermic, a large reference power was used (30 µCal/sec).  
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Table 1: Experimental parameters used in ITC analysis. 
 
Water 
– 
Water 
Methanol – 
Water 
Buffer – 
Buffer 
Protein 
– Buffer 
Buffer – 
RNA 
Protein – RNA 
snR34 
wt 
snR34 
Truncated 
Total No. of 
Injections: 
30 28 30 
Cell 
Temperature 
(
o
C): 
30 
Reference 
Power 
(µCal/s): 
15 30 15 
Initial Delay 
(s): 
60 60 60 600 600 120 600 
Nhp2 Syringe 
Concentration 
(µM): 
0 0 0 100 0 100 40 
snoRNA Cell 
Concentration 
(µM): 
0 0 0 0 5 5 2.8 
Stirring Speed 
(RPM): 
450 
Feedback 
Mode/Gain: 
Hi 
Injection Parameters 
Volume 
(mL): 
10 10 10 10 10 10 10 
Duration (s): 20 20 20 20 20 20 20 
Spacing (s): 300 300 300 300 300 300 300 
Filter (s): 2 2 2 2 2 2 2 
ITC 
Equilibration 
Options  
Fast Equilibration, Auto 
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After analysis of the wild-type system, a smaller more conservative reference power (15 
µCal/sec) was selected for analysis of the truncated RNA. As controls, water-water, methanol-
water, buffer-buffer, protein-buffer, and buffer-RNA controls were performed. Data was fit in the 
Origin 7 software (MicroCal™ Software, Inc.) using a two-binding-site model. 
II.IV Results 
Recombinant Expression and Purification of S. cerevisiae H/ACA protein Nhp2 
H/ACA structural protein Nhp2 was recombinantly expressed in E. coli BL21 (DE3) Rosetta cells 
at 37°C. Optical density readings at 600 nm of the E. coli BL21 (DE3) Rosetta cells containing 
pET28a-Nhp2 were plotted in comparison to E. coli BL21 (DE3) Rosetta cells without plasmid to 
determine the cell growth efficiency of both strains (Fig. 6 A). In parallel, cell samples were 
collected upon induction to confirm the expression of Nhp2 by SDS-PAGE. A band of ~ 21 kDa 
is observed with increasing intensity over a three hour time period, indicating that the observed 
band is His-tagged Nhp2 (Fig. 6A).  
 His-tagged Nhp2 was purified using a two-step purification procedure including Ni2+-
sepharose affinity chromatography and SP Sepharose Fast Flow cation exchange 
chromatography. E. coli BL21 (DE3) Rosetta cells containing His-Nhp2 were opened in a cell 
lysis buffer, and the resulting cellular lysate was loaded onto a Ni-Sepharose affinity 
chromatography column. Following washing with cell lysis buffer, His-Nhp2 was subsequently 
eluted from the column using a gradient with an increasing imidazole concentration. A large peak 
in absorbance at 280 nm is observed in the chromatogram at 250 mM imidazole (Fig. 6B). 
Fractions from this peak were analyzed by SDS-PAGE. As expected, a band of approximately 21 
kDa corresponding to His-Nhp2 is observed in fractions corresponding to the peak in the 
chromatogram (Fig. 6B). In addition to the prominent 21 kDa band, several larger and smaller 
molecular weight bands are visible indicating that further purification of Nhp2 is required.  
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Figure 6: Recombinant expression and purification of S. cerevisiae H/ACA protein Nhp2. A. 
Recombinant expression of His-Nhp2 wild-type in E. coli BL21 (DE3) Rosetta cells. Cells were grown at 
37 oC with cell samples taken for three hours after induction. Cell samples were analyzed by SDS–PAGE, 
and cellular growth (triangles) was plotted in comparison to E. coli BL21 (DE3) Rosetta cells (squares) 
standard growth. His-tagged Nhp2 has a molecular weight of ~21 kDa. B. Nickel sepharose affinity 
chromatography purification of His-Nhp2 wild-type. Collected fractions were analyzed by SDS–PAGE. C. 
Cation exchange chromatography purification of His-Nhp2 wild-type. Collected fractions were analyzed by 
SDS–PAGE. D. His-tagged Nhp2 F146H and V122M variants were expressed and purified in the same 
manner as Nhp2 wild-type and were analyzed by SDS-PAGE. 
As Nhp2 has a pI of 9.1 (as computed from its amino acid composition using the tools 
section on the UniProt database [Swiss Institute of Bioinformatics]), it is anticipated that it will 
interact with a cation exchange chromatography column with a strong affinity at low salt and a 
pH 8.0. Therefore, His-tagged Nhp2 was further purified by SP Sepharose Fast Flow cation 
exchange chromatography. Nhp2 was eluted from the column using a gradient from low to high 
salt. The resulting chromatogram displays a large peak during Nhp2 elution at 600 mM KCl (Fig. 
6C). Samples taken from the corresponding fractions display a prominent band of approximately 
21 kDa strongly indicating that His-tagged Nhp2 was successfully further purified with the 
additional higher and lower molecular weight contaminants significantly reduced (Fig. 6C). The 
presence of a single band corresponding to His-Nhp2 indicates that Nhp2 has been successfully 
purified.  
As mentioned above, the rare inherited disease DC autosomal form has been linked to three 
substitutions found within the human H/ACA structural protein Nhp2: V126M, Y139H, and 
X154R [76]. To determine the possible effects such DC substitutions in Nhp2 may have on RNA 
recognition, two S. cerevisiae Nhp2 variants, V122M and F146H, corresponding to mutations in 
human Nhp2 found in DC patients, were created through site-directed mutagenesis and purified. 
S. cerevisiae Nhp2 DC variants F146H and V122M were purified using the same procedure as for 
wild-type Nhp2. Samples taken from purified and concentrated Nhp2 wild-type, F146H, and 
V122M were analyzed by SDS-PAGE (Fig. 6D). Analysis by Image J 1.41 (Apache Software 
Foundation) indicated that all protein preparations are ~95% pure.   
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In vitro Synthesis of S. cerevisiae H/ACA snoRNA snR34 
Eukaryotic H/ACA snoRNAs are composed of two irregular hairpin structures linked by a hinge 
sequence [23]. A secondary structure model of S. cerevisiae H/ACA snoRNA snR34 is shown in 
Figure 7A outlining essential features of all H/ACA snoRNAs. The hinge region (Box H) 
following the 5’ hairpin consists of an ANANNA sequence. Located downstream of the 3’ 
hairpin structure is the Box ACA consisting of an ACA sequence [89]. The first step towards 
studying the protein-RNA and RNA-RNA interactions between H/ACA snoRNA snR34 and the 
core proteins and substrate RNA is to in vitro synthesize snR34. To this end, the DNA template 
for H/ACA snoRNA snR34 wild-type was amplified from pTZ19r-snR34 plasmid DNA by PCR 
using appropriate primer pairs in which the reverse primer was 2'-O-methylated at the 5’ end. The 
2’-O-methylation prevents the addition of non-specific nucleotides to the 3’ end of the snoRNA 
during the in vitro transcription. The amplified DNA template was analyzed by agarose gel 
electrophoresis in order to control for the correct template size and to estimate its concentration. 
A band of ~250 bp is observed corresponding to the correct size of snR34 wild-type gene plus a 
T7 promoter region, indicating that the DNA template for snR34 wild-type was correctly 
amplified (Fig. 7B). snR34 wild-type was then produced in a four hour in vitro transcription 
reaction. Subsequently, the DNA template was degraded by DNase I. The resulting RNA product 
was purified by an AX500 Nucleobond column (Machery-Nagel). RNA samples were collected 
after the in vitro transcription and during purification and were analyzed by urea–PAGE. As 
shown in Figure 7B, significant amounts of RNA product are visible after both the in vitro 
transcription and the purification leading to the conclusion that snR34 wild-type was successfully 
synthesized and purified.    
 As a first step to determine the specific binding site of H/ACA protein Nhp2 on H/ACA 
snoRNA snR34, a truncated version of snR34 was synthesized. The truncated construct removes 
the 3’-hairpin structure leaving the hinge sequence and the 5’ hairpin only as outlined by a black 
 37 
 
box in Figure 7A. The snR34 truncation was synthesized using the same experimental set up used 
for snR34 wild-type. The amplified DNA template has the expected band size of ~200 bp 
corresponding to the correct size of truncated construct with a T7 promoter region (Fig. 7C). 
Urea-PAGE analysis of the resulting RNA samples collected from the subsequent in vitro 
transcription and purification shows significant amounts of RNA product suggesting that 
truncated snR34 was successfully synthesized (Fig. 7C). Analysis of the RNA products by urea-
PAGE shows that both RNA preparations consist predominantly of a single RNA species thus 
indicating that little degradation of the RNA product took place during the in vitro transcription 
and purification (Fig. 7B-C).  
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Figure 7: Synthesis of S. cerevisiae H/ACA snoRNA snR34 wild-type and truncated. A. Secondary 
structure of H/ACA snoRNA snR34. The pseudouridylation pockets are indicated in red and the substrate 
RNA is indicated in grey. snR34 5’-hairpin targets U2826, and snR34 3’-hairpin targets U2880 of the 25S 
rRNA. The conserved box ANANNA and ACA are highlighted in blue. The black box indicates a 
shortened RNA construct which is used to identify the binding site of Nhp2. B. Synthesis of snR34 wild-
type DNA template and the in vitro transcription and purification of snR34 wild-type H/ACA snoRNA. C. 
snR34 truncation DNA template and in vitro transcription and purification of truncated snR34 H/ACA 
snoRNA.  
Towards the identification of the minimal H/ACA snoRNA binding site for Nhp2 by EMSA  
By using [
32
P]-labeled snR34 in EMSA, I was able to detect and quantify the interaction of Nhp2 
with H/ACA snoRNA. 2 nM of radiolabeled snR34 wild-type was incubated with increasing 
concentrations of Nhp2 wild-type, and the snR34-Nhp2 interaction was analyzed by native-
PAGE. An upwards shift of the RNA band was observed upon addition of Nhp2 (Fig. 8A) which 
is indicative of complex formation between snR34 and Nhp2. The intensity of the shifted band 
increases with increasing Nhp2 concentration over the whole concentration range. The fact that a 
band corresponding to free RNA remains visible at the highest tested Nhp2 concentration (72 
nM) suggests that complete binding has not been reached yet. By plotting the concentration of 
Nhp2 versus the quantified intensity of the shifted band (Image J 1.41 [Apache Software 
Foundation] pixel quantification), an approximate value for the KD of the interaction between 
Nhp2 and snR34 wild-type can be extrapolated to be 36 +/- 9 nM. While Nhp2’s archaeal 
homolog L7Ae can interact with kink-turn structural motifs with high specificity, Nhp2 however 
does not have this specificity. This puzzling trait of Nhp2 puts forth several questions including 
how Nhp2 specifically recognizes and binds H/ACA snoRNAs. To answer this question, the 
minimal binding site of Nhp2 on the H/ACA snoRNA must be identified by successively 
shortening the snoRNA and studying the resulting interaction between Nhp2 and the shortened 
construct. Towards this aim, qualitative EMSA was used to analyze the interaction between Nhp2 
wild-type and truncated snR34 (outlined in Fig. 7A). Similarly to the Nhp2-snR34 wild-type 
system, 2 nM of radiolabeled snR34 truncation was incubated with increasing concentrations of 
Nhp2 wild-type, and the RNA-Nhp2 interaction was analyzed by native-PAGE. An observable 
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shift in band location is visible with increasing concentrations of Nhp2 (Fig. 8B), suggesting an 
interaction between truncated snR34 and Nhp2 wild-type.  
 
Figure 8: Analysis of S. cerevisiae Nhp2 wild-type interaction with snR34 wild-type and truncated 
snR34 by EMSA. H/ACA snoRNA, snR34, was radiolabeled at its 5’ end with [32P]. snR34 concentrations 
remained constant at 2 nM while increasing concentrations of Nhp2 were titrated. All Nhp2-snR34 
interactions were analyzed on an 8% native-PAGE and visualized using autoradiography. A. EMSA 
analysis of the interaction between Nhp2 wt and snR34 wild-type. The intensities of the shifted band were 
estimated by Image J 1.41 (Apache Software Foundation) and plotted against the Nhp2 concentration, in 
order to estimate the KD (36 +/- 9 nM). B. EMSA analysis of the interactions between Nhp2 wt and snR34 
truncation.  
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Analysis of the interaction between S. cerevisiae Nhp2 and H/ACA snoRNA snR34 by 
isothermal titration calorimetry 
Isothermal titration calorimetry (ITC) is a highly sensitive, powerful technique used to study the 
thermodynamics of the binding of the two interacting molecules [90]. As the name implies, ITC 
is based on the gradual titration of a ligand into a solution of its binding partner. By monitoring 
the amount of energy over time required to maintain a constant temperature within the sample 
cell, ITC is able to provide essential information on the binding affinity, stoichiometry and 
thermodynamics of an interaction [90].  
 Here, ITC was used to further examine the binding affinity, stoichiometry and 
thermodynamic properties of the S. cerevisiae Nhp2 and H/ACA snoRNA snR34 wild-type and 
truncation interactions. 100 µM Nhp2 was titrated into 5.0 µM snR34 wild-type, while 40 µM 
Nhp2 was titrated into 2.8 µM truncated snR34. In both experimental setups, injection of Nhp2 
produced an upward inflection observed in the raw ITC data indicating that an increase in energy 
over time was required to maintain the system at a constant temperature (Fig. 9A, B), thus 
indicating that an endothermic reaction was occurring. The gradual decrease in the magnitude of 
each inflection with the increase of Nhp2 concentration corresponds to increasing binding of 
Nhp2 to the RNA (Fig. 9A, B). The small inflections at the end of each titration can be attributed 
to energy released from the heat of dilution and mechanical energy as protein saturation has 
occurred. Controls to account for the heat of dilution and mechanical energy released during this 
experiment were performed and found to produce minimal to no effect on the system energy (data 
not shown). By integrating the area under each inflection point, a thermogram of the injection 
heats for the specific amount of Nhp2 added at a specific injection point was generated. 
Quantification of these injection heats produced from Nhp2 interactions with both snR34 wild-
type and truncation revealed a biphasic behavior in which the first Nhp2 binding event is 
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enthalpically driven with enthalpies of binding of H1wt = -3000 +/- 9000 cal/mole and H1truncated 
= -1600 +/- 400 cal/mole respectively. 
 
Figure 9: Analysis of S. cerevisiae Nhp2 wild-type interaction with snR34 wild-type and truncated 
snR34 by ITC. All ITC analysis was performed at 30 oC on a VP ITC Microcalorimeter. Raw data and H 
graph generated from the interactions between Nhp2 wt and A. snR34 wt. and B. snR34 truncation. 
 The enthalpies of binding for the second Nhp2 binding event were determined to be 
H2wt = 14,000 +/- 11,000 cal/mole and H2truncated = 8500 +/- 2000 cal/mole, indicating an 
entropically driven reaction is occurring. The binding entropy was calculated from H and K 
using Go = -RT lnK = Ho-TSo. Comparison of the KD value for the first binding event in the 
Nhp2-snR34 wild-type interaction (12 +/- 8 nM) determined by ITC with that estimated from the 
EMSA analysis (36 +/- 9.0 nM) shows that both values are in the same order of magnitude (low 
nanomolar range), similar to the previously determine KD value for the interaction between Nhp2 
and H/ACA snoRNA snR36 (4 nM, [39]). A complete comparison of thermodynamic parameters 
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determined by ITC for the interactions between Nhp2 and snR34 wild-type and truncation can be 
found in Table 2. 
Table 2: Comparison of parameters for snR34 wild-type and truncated snR34 determined by ITC 
where n, KD, H, and S are stoichiometry, dissociation constant, enthalpy of binding and 
entropy of binding. 
ITC Determined 
Parameter 
Nhp2-snR34 wt Interaction 
Nhp2-snR34 truncation 
Interaction 
n1  1.1 +/- 0.4  1.6 +/- 0.1  
KDI  12 +/- 8 nM  2.4 +/- 1.6 nM  
H1 -3,000 +/- 9,000 cal·mole
−1
 -1,600 +/- 400 cal·mole
−1
 
S1  26.8 cal·mole
−1
K
−1
 34.3 cal·mole
−1
K
−1
  
n2  1.4 +/- 0.5  0.9 +/- 0.1  
KD2  40 +/- 80 nM  29 +/- 13 nM  
H2  14,000 +/- 11,000 cal·mole
−1
 8,500 +/- 2,000 cal·mole
−1
 
S2  79.6 cal·mole
−1
K
−1
   62.6 cal·mole
−1
K
−1
   
 
Analysis of the effects of Dyskeratosis congenita substitutions in S. cerevisiae Nhp2 on the 
interaction with H/ACA snoRNA snR34  
The autosomal form of the multisystem disease DC is associated with three substitutions found 
within the human Nhp2: V126M, Y139H, and X154R [76]. The generation of two DC 
substitutions in S. cerevisiae Nhp2, V122M and F146H, which correspond to the mutations found 
in human Nhp2 DC patients allows for the in vitro study of the effects such substitutions in Nhp2 
may have on RNA recognition. To examine the effects these substitutions have on Nhp2’s 
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interaction with H/ACA snoRNA, Nhp2 variants, F146H and V122M, were used in EMSA 
analysis with snR34 wild-type.    
 
Figure 10: Analysis of S. cerevisiae Nhp2 Dyskeratosis congenita variants F146H and V122M 
interaction with snR34 wild-type by EMSA. snR34 wild-type concentration remained constant at 2 nM 
while increasing concentrations of Nhp2 were titrated in. All Nhp2-snR34 interactions were analyzed by 
8% native-PAGE. A. EMSA analysis of the interaction between Nhp2 F146H and snR34 wt with a KD 
estimated of 8.0 +/- 2.0 µM. B. Analysis of the interactions between Nhp2 V122M and snR34 wt using 
EMSA, where a KD of 4.4 +/- 0.6 µM was estimated.  
2 nM of radiolabeled snR34 wild-type was incubated with increasing concentrations of 
Nhp2 F146H or V122M respectively, and their interactions were analyzed by native PAGE. The 
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titration of both Nhp2 F146H and V122M to snR34 wild-type produces a shifted band of higher 
molecular weight visible in Figure 10A-B, suggesting an interaction between snR34 wild-type 
and Nhp2 F146H and V122M is occurring. Complex formation is also supported by the decrease 
in band intensity corresponding to free RNA (Fig. 10A- B). KDs of 8.0 +/- 2.0 µM and 4.4 +/- 0.6 
µM were estimated for Nhp2 F146H and V122M, respectively, from the dependence of the 
shifted band intensity on the Nhp2 concentration. When compared with the estimated KD (36 +/- 
9 nM) calculated from the snR34-Nhp2 wild-type interaction, a notable decrease in RNA affinity 
is observed for Nhp2 F146H and V122M indicating that both substitutions of Nhp2 impair RNA 
binding. 
Analysis of Nhp2 wild-type and Dyskeratosis congenita variants specificity for H/ACA 
snoRNA snR34 
Nhp2 has been reported to bind non-specifically to RNA molecules when alone [39, 68]. Taking 
this into consideration we must question whether the interactions we see within our binding 
assays between Nhp2 and snR34 are the result of specific or non-specific binding. To test Nhp2’s 
binding specificity for H/ACA snoRNA snR34, a tRNA competition experiment was performed 
with Nhp2 wild-type, and Nhp2’s two DC variants V122M and F146H. 2 nM of radiolabelled 
snR34 wild-type and 10 µM unlabeled tRNA were used in all three chase experiments. A 
concentration of 50 nM of Nhp2 wild-type was added to snR34 alone and to snR34 in the 
presence of tRNA. Similarly, 30 µM Nhp2 DC variants V122M and F146H were added to snR34 
alone and to snR34 plus tRNA. Analysis of the shifted band intensities in the presence and 
absence of tRNA was performed by Image J 1.41 (Apache Software Foundation) and is 
summarized in Table 3. The presence of tRNA appears to have an effect on Nhp2 binding to 
snR34, as a decrease in the shifted band intensities in the presence of tRNA is visible for Nhp2 
wild-type (Fig. 11A), F146H (Fig. 11B lanes 2-3), and V122M (Fig. 11B lanes 4-5).   
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Figure 11: Analysis of S. cerevisiae Nhp2 specificity for H/ACA snoRNA snR34. Nhp2 wt, V122M, and 
F146H were incubated with radiolabeled snR34 wild-type in the presence and absence of unlabeled tRNA. 
snR34 concentration remained constant at 2 nM while tRNA concentration remained constant at 10 µM. 
tRNA chase experiments were analyzed by 8% native-PAGE. A. Nhp2 wt. (50 nM). B. Nhp2 V122M (30 
µM, lanes 2-3) and F146H (30 µM, lanes 4-5).  
Table 3: Comparison of band intensities of Nhp2-snR34 complexes in the presence and absence 
of tRNA. 
Nhp2 wt Nhp2 V122M Nhp2 F146H 
snR34 
alone 
snR34 
+ 
tRNA 
Percent 
Change 
in 
Binding 
snR34 
alone 
snR34 
+ 
tRNA 
Percent 
Change 
in 
Binding 
snR34 
alone 
snR34 
+ tRNA 
Percent 
Change 
in 
Binding 
11,200 2,400 78 % 45,000 26,000 42 % 47,000 36,000 23 % 
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II.V Discussion  
Binding affinity of Nhp2 wild-type and Nhp2 DC variants to H/ACA snoRNA snR34 
The small RNA-binding protein Nhp2 is an important structural member of the eukaryotic 
H/ACA snoRNP complex which is responsible for the introduction of pseudouridine 
modifications in many cellular RNAs. Mutations in Nhp2 (V126M, Y139H, and X154R) have 
been directly linked to the autosomal recessive form of the rare inherited disease DC. The 
determination of Nhp2’s binding affinity to H/ACA snoRNAs allows for the study of the effects 
such DC substitutions have on Nhp2 interaction with H/ACA snoRNAs. Here approximate 
dissociation constant values were extrapolated from the EMSA analysis of the interactions 
between Nhp2 wild-type, V122M, and F146H with snR34 wild-type to be KD(wt) = 36 +/- 9.0 
nM, KD(F146H) = 8.0 +/- 2.0 µM, and KD(V122M) = 4.4 +/- 0.6 µM. While these KD values are 
only estimations derived from the quantification of the shifted band intensities, it is clear that the 
binding affinity of Nhp2 to H/ACA snoRNA snR34 is dramatically affected by approximately a 
100 fold decrease when DC substitutions are introduced into Nhp2.  
 Valine 126 (valine 122 in yeast) and tyrosine 139 (phenylalanine 146 yeast) are highly 
conserved residues within the human H/ACA structural protein Nhp2 [75, 84]. Both residues are 
also directly involved in packing of the hydrophobic core of the protein, indicating an important 
role in Nhp2’s structural integrity and stability [75, 84]. Valine 126 is positioned directly above 
the α helix which interacts with Nop10; replacement of the valine residue with a bulkier 
methionine residue destabilizes the interaction between Nhp2 and Nop10 presumably by altering 
the core packing of Nhp2 [75]. Tyrosine 139 has an important role in Nhp2’s protein structure 
and stability as tyrosine 139 is also located within the interior of the Nhp2 [75]. Analysis of 
Nhp2’s primary sequence shows that tyrosine 139 is conserved as a hydrophobic residue in all 
species. The introduction of a histidine residue dramatically affects the overall core packing of 
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Nhp2 and thus the stability of the protein [75]. Similarly to the effects on Nop10 interactions, it 
can be envisioned that destabilization of the Nhp2 hydrophobic core also affects RNA binding as 
shown here. 
 In the cell, Nhp2’s association with H/ACA snoRNPs and thus with H/ACA snoRNAs is 
dependent on its interaction with the Nop10-Cbf5 binary complex [68, 82]. As shown here, 
destabilization of the packing of Nhp2’s hydrophobic core dramatically affects Nhp2’s affinity to 
H/ACA snoRNAs thus impairing the assembly of the pre-H/ACA RNP complex. Interaction 
studies of archaeal H/ACA snoRNP complex have shown that the absence of L7ae (the archaeal 
homolog of Nhp2) dramatically affects placement of substrate RNA within the catalytic site. As 
H/ACA snoRNPs are involved not only in RNA modifications but also in telomerase RNA 
maturation, impaired pre-RNP assembly would also result in the degradation of the telomerase 
RNA. Without the telomerase RNA template, replenishment of the telomere repeating sequence 
would not occur resulting in the occurrence of critically short telomere sequences often observed 
in DC patients.   
S. cerevisiae Nhp2 recognition of H/ACA snoRNAs 
Using [
32
P]-labeled snR34 in EMSA analysis, we have been able to detect and quantify 
the interaction between Nhp2 and H/ACA snoRNA snR34 wild-type with an estimated KD of 36 
+/- 9.0 nM. This KD value within the low nM range is in the same order of magnitude as in the 
previous reported Nhp2-H/ACA snoRNA interaction studies performed by the Henry lab where 
the interaction between Nhp2 and H/ACA snoRNA snR36 was analyzed, and a KD of 4 nM was 
determined using EMSA [39]. In an effort to illuminate the details of Nhp2’s interaction with 
H/ACA snoRNAs, I have begun to determine of the minimal binding site of Nhp2 on H/ACA 
snoRNAs through the successive shortening of the H/ACA snoRNA snR34. Analysis of the first 
Nhp2-snR34 truncation interaction by EMSA demonstrates that removal of the conserved box 
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ACA motif and the 3’-hairpin have no effect on Nhp2’s interaction with the guide RNA as 
binding is observed in a similar Nhp2 concentration range. Nhp2’s ability to interact with the 
guide RNA in the absence of both the box ACA motif and the 3’-hairpin may partially be 
explained through Nhp2’s archaeal homolog L7Ae. Like Nhp2, L7Ae interacts with H/ACA 
snoRNAs at the tip of each irregular-hairpin, and thus Nhp2 might still be able to bind to the first 
hairpin when we removed the second [28, 39, 87]. Similar findings have been reported with 
another guide RNA [28, 39, 87]. While Nhp2 lacks the ability to interact with kink-loop structural 
motifs, several basic residues within the conserved RNA binding region of L7Ae are found in 
Nhp2 suggesting a common mechanism for interacting with H/ACA snoRNAs [24]. The 
difference observed between Nhp2’s interaction with H/ACA snoRNAs and that of L7Ae may 
also be attributed to five signature amino acids which are variable and unique to each member of 
the L7Ae/L30 protein family [40]. These five signature amino acids flank the RNA-binding 
region and appear to confer RNA recognition specificity which is distinct to each member of the 
L7Ae/L30 protein family [40]. Replacement of L7Ae’s signature RNA recognition residues with 
those of Nhp2 results in loss of L7Ae’s kink-loop binding capabilities and a reduction in L7Ae’s 
kink-turn binding abilities [40].  
EMSA analysis is a useful tool in determining the binding affinity of Nhp2 to H/ACA 
snoRNAs. EMSA does however have several limitations which influence the accuracy of the 
experimental data collected from such analyses. EMSA is a non-equilibrium method, and hence 
there is the possibility of the protein-RNA complex being disrupted during electrophoresis. The 
disruption of the complex would thus result in the underestimation of protein binding. Therefore, 
the determined KD’s are estimates only, as the relative percentage of the RNA-protein complex 
might be underestimated. Additionally, EMSA analysis of the interaction between Nhp2 and 
snR34 can only give a clear indication that the two recombinant components are interacting, it 
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does not provide information on where the components are interacting or how, providing a rather 
shallow view of the protein-RNA interaction occurring.  
To address the limitation presented in EMSA analysis, a second more precise quantitative 
technique, ITC, was used to examine the binding affinity, stoichiometry and thermodynamic 
properties of the Nhp2 and H/ACA snoRNA snR34 interaction. As ITC is an equilibrium-based 
technique, it is capable of providing more quantitative information on protein binding. ITC is an 
extremely sensitive and direct technique which measures the amount of energy over time needed 
to maintain a constant temperature within the sample cell as complex formation occurs [90]. 
Using L7Ae’s interaction with archaeal H/ACA snoRNAs as a model, it was believed that Nhp2 
would interact with eukaryotic bipartite H/ACA snoRNAs in a similar manner to L7Ae’s 
interactions in which one Nhp2 protein would associate with each hairpin structure. Upon 
analysis of the Nhp2-snR34 wild-type and Nhp2-snR34 truncation interactions, it became 
apparent that we were working with a two-site binding model, where the first Nhp2 binding event 
is enthalpically driven, while the second Nhp2 binding event is entropically driven. As high RNA 
and protein concentrations were used, Nhp2 presumably binds to both sites simultaneously, 
explaining why all inflections are upward although the first binding event is enthalpically driven. 
Interestingly, examination of the Nhp2-snR34 truncated results revealed no significant alteration 
in the stoichiometry possibly suggesting that both binding events occur on the 5’-hairpin. This 
raises the question whether Nhp2 can bind to the 3’ hairpin as predicted and where the two 
binding sites are located on the 5’ hairpin.    
Within the raw ITC data a small negative inflection is visible directly after the observed 
positive inflections. This pattern of positive and negative inflections is suggestive of a binding 
event followed by a conformational change within the newly formed complex as protein binding 
can be endothermic, withdrawing energy from the system, while a conformational change 
typically is exothermic, releasing energy from the system. These features of Nhp2’s interactions 
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with snR34 wild-type and truncation are similar to those observed in L7Ae’s binding of archaeal 
H/ACA snoRNAs. Binding of L7Ae to an archaeal H/ACA snoRNA induces a conformational 
change within the guide RNA forming the notable 120
o
 bend in the phosphodiester backbone of 
the snoRNA characteristic to all kink-loop and kink-turn structural motifs [28]. As Nhp2 shares 
many conserved residues in the RNA-recognition region with L7Ae, it is reasonable to 
hypothesize that the mechanism of interaction between the two homologues will be conserved as 
well, suggesting that binding of Nhp2 to eukaryotic H/ACA snoRNA may also induce a 
conformational change within the snoRNA. To determine whether Nhp2’s interaction mechanism 
is similar to that of L7Ae, the minimal binding site of Nhp2 on the H/ACA snoRNA must be 
established. Therein, we can examine the binding specificity of Nhp2 by systematically changing 
nucleotides within the minimal binding site of H/ACA snoRNAs. This would allow in turn for the 
determination of a more precise binding affinity, stoichiometry, and thermodynamic properties 
for the interaction between Nhp2 and H/ACA snoRNAs. Additionally, to observe whether Nhp2 
induces a similar kinking effect within the H/ACA snoRNA as L7Ae, the crystal structure of 
Nhp2 bound to the H/ACA snoRNA would need to be determined, as well as the crystal structure 
of the H/ACA snoRNA in the absence of Nhp2. 
While the advancements in ITC equipment have made it an increasingly popular 
technique for obtaining and analyzing the quantitative thermodynamic proprieties of biological 
systems, it has several limitations as an analytical tool. ITC experiments require large amounts of 
sample, which may be difficult to produce when working with recombinant components [90]. 
Additionally, the data gathered from ITC analysis only provide information on how the respective 
biological components are interacting, but not where they are interacting [90]. While the 
stoichiometry, binding affinity, and thermodynamic properties of a system provide invaluable 
information, without knowing the interaction sites, such values often raise more questions than 
answers [90].  
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Nhp2’s specificity for H/ACA snoRNAs 
The binding specificity of a protein is determined by several factors including the affinity (KD) of 
the protein for different ligands and the concentration of these different ligands within the cell. If 
a protein interacts with several different ligands in the cell, this binding is characterized as being 
unspecific. Binding is specific when a protein interacts only with a single ligand in the cell either 
because the affinity for this ligand is much higher than for other similar ligands or because this 
ligand is present in a much higher concentration in the cell than other ligands. 
 Nhp2 has previously been reported to bind non-specifically to RNA molecules, bringing 
into question whether the interaction observed in our binding assays is specific or unspecific [39, 
68]. To test for Nhp2’s RNA specificity, a tRNA competition experiment was performed with 
Nhp2 wild-type, and Nhp2’s two DC variants V122M and F146H. Analysis of the competition 
experiments showed a strong effect on Nhp2’s interaction with H/ACA snoRNA snR34 wild-
type. Such a result suggests that Nhp2’s affinity for tRNA is within a range from low nano-molar 
to 5 µM (half of the added tRNA concentration), as addition of tRNA clearly affects Nhp2-snR34 
wild-type binding. A low affinity of 5 M to tRNA would be sufficient to explain the observation 
as in this case Nhp2 would quantitatively bind to tRNA which is present at high concentrations 
(10 M). Thereby, the concentration of free Nhp2 which can bind to snR34 would be highly 
reduced. Another explanation for the results observed in the tRNA competition assay would be 
that Nhp2’s affinity for tRNA was equal to or stronger than its affinity for snR34. However, 
under in vivo cellular conditions this would seem highly unlikely as Nhp2 has been document 
through in vivo pull down assays to interact specifically with H/ACA snoRNAs and protein 
components [39, 68, 91]. The effect observed in the snR34-Nhp2 mutant tRNA chase experiment 
are the result of approximately 10 µM of Nhp2 interacting with the tRNA and 20 µM of Nhp2 
interacting with the H/ACA snoRNA.  
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 A review of the literature shows comparable results when Nhp2 is exposed to RNA 
structures containing irregular hairpins similar to those found in H/ACA snoRNAs [39]. It has 
also been reported that while Nhp2 does interact with RNA molecules in vitro, it does not interact 
with all RNA molecules equally, displaying extremely poor interactions with single-strand 
poly(A) and poly(U) RNAs, and little affinity for perfect double stranded RNA molecules [39]. 
As tRNA’s clover leaf structure contains several hairpin structures, it is not unreasonable to 
hypothesize that Nhp2 may recognize secondary RNA structures rather than specific residues 
within the RNA’s primary sequence. If Nhp2 specificity arises from its ability to recognize and 
interact with certain secondary structures of RNA (irregular hairpins), it is not unreasonable to 
hypothesize that Nhp2 would have a similar affinity to tRNA as it does to H/ACA snoRNA as 
both contain irregular hairpin secondary structures. To test this hypothesis, Nhp2’s affinity for 
tRNA would need to be analysed in a comparable manner as Nhp2’s affinity for H/ACA 
snoRNA, potentially using EMSA and ITC to determine the thermodynamic properties of the 
interaction. It has also been well documented that Nhp2’s association with the H/ACA snoRNP 
complex is dependent on the formation of a Nop10-Cbf5 binary complex [68, 82]. The presence 
of this Nop10 –Cbf5 binary complex may provide Nhp2 with the RNA binding specificity 
observed in other L7Ae/L30 protein family members. While both hypotheses of Nhp2’s 
interaction specificity have merit, further research is required to ultimately determine how Nhp2 
interacts with H/ACA snoRNAs [68, 82].    
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 54 
 
III.I  Introduction 
Cbf5, a Member of the TruB Pseudouridine Synthase Family 
S. cerevisiae H/ACA catalytic protein Cbf5 was first identified as a low-affinity centromere-
binding protein, sharing similar charge distribution and a sequence repeat with known 
microtubule-associated proteins [92]. Later sequence analysis revealed significant sequence 
similarity with other bacterial and eukaryotic proteins, including the E. coli pseudouridine 
synthase TruB [33].  
To date five pseudouridine synthase families within archaea, bacteria, and eukaryotes are 
known: RluA, RsuA, TruA, TruB, and TruD. Structural analysis of the five pseudouridine 
synthase families has shown a common core domain and a highly conserved active-site cleft [13]. 
The pseudouridine synthase core domain is composed of an eight stranded mixed β-sheet bisected 
by a highly conserved hydrophobic active-site cleft, flanked with numerous helices and loops 
[13]. Within the active site loop is a universally conserved aspartate residue. The aspartate found 
within the active site loop has been shown to be essential for catalysis in all five pseudouridine 
synthase families as substitution of this residue abolishes in vivo pseudouridine formation [21, 
37]. In addition to the absolutely conserved aspartic acid, two other highly conserved polar 
residues are found within the active site cleft, a lysine or an arginine residue and an invariant 
tyrosine residue (except in TruD) [13]. The side chain of the lysine or arginine residue interacts 
with the invariant tyrosine residue and the catalytic aspartate residue to form a buried salt bridge 
[13]. Despite the shared core domain, the five pseudouridine synthase families share little 
sequence similarity and contain a variety of independent N- and C-terminal extensions.   
E. coli TruB is responsible for the isomerisation of uridine 55 to pseudouridine within the 
T- loop of elongator tRNAs [14]. The TruB pseudouridine synthase family contains a C-terminal 
pseudouridine and archaeosine transglycosylase (PUA) domain and a thumb-like loop protrusion 
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flanking the active-site cleft, both of which are essential for pseudouridylation [36, 93]. Structural 
analysis of TruB and Cbf5 demonstrated that both share a similar structure, indicating that Cbf5 is 
a member of the TruB pseudouridine synthase family (Fig. 12) [15]. Like TruB, Cbf5 contains a 
large N-terminal catalytic domain and a small C-terminal PUA domain. The N-terminal catalytic 
domain of Cbf5 can be divided into two subdomains, D1 and D2, forming a catalytic cleft 
between them [24]. The active site lies towards the bottom of the catalytic cleft [35, 94]. The C-
terminal PUA domain contains a mix of α-helix and β-strand secondary structures [35, 94].  
While the overall structure of Cbf5 is similar to TruB, there are three fundamental 
structural differences between the two proteins. The N-terminus of yeast Cbf5 holds an additional 
extension compared to TruB allowing the N-terminus to wrap around the C-terminal PUA 
domain forming an extra β-strand (Fig. 12) [94]. The catalytic domain of TruB contains a well 
defined thumb loop which is responsible for the placement of the substrate RNA within the 
catalytic site of TruB (Fig. 12) [35, 94]. Cbf5 contains a thumb loop structure which is 
considerably smaller than TruB’s [35, 94]. To compensate for this loss, H/ACA protein Gar1 
interacts with Cbf5 within the thumb loop region allowing for proper placement of substrate RNA 
within the catalytic site [25]. The C-terminal PUA domain of Cbf5 is significantly larger than 
TruB’s, containing a phylogenetically conserved extension elongating the PUA domain (Fig. 12) 
[35, 94]. The structural differences observed between Cbf5 and TruB might explain Cbf5’s need 
of a complex RNP system for optimal catalytic activity.  
 
 56 
 
 
 57 
 
 
Figure 12: Sequence alignment and structure of H/ACA catalytic protein Cbf5. A. Multiple sequence 
alignment of Cbf5. Of the five aligned sequences two are eukaryotic: Saccharomyces cerevisiae (ScerCbf5) 
and Homo sapiens (HsapCbf5), two are archaeal: Methanocaldococcus jannaschii (MjanCbf5) and 
Pyrococcus furiosus (PfurCbf5), and one is bacterial: Escherichia coli (EcolTruB). The secondary structure 
elements are shown above the sequences, with α-helices depicted as rectangles and β-strands as arrows. 
The secondary structural elements indicated above the sequence align are determined by Li et al. [24]. 
Completely conserved residues among the sequences aligned are shaded in black, and residues with at least 
60% conservation are shown in grey. N-terminal and C-terminal extensions are outline by blue boxes and 
the E. coli TruB thumb loop is outlined in red. The alignment was prepared using ClustalW (EMBL-EBI) 
and Gene Doc (Dr. Nicholas Hugh). B. Superposition of M. jannaschii Cbf5 (purple, PDB 2APO [35]) and 
E. coli TruB (yellow, PDB 1K8W [36]) crystal structures. The N-terminal Cbf5 extension is indicated in 
red; the C-terminal extension is not resolved in crystal structure. The TruB thumb loop is indicated in 
green. The structural alignment was made with Pymol Molecular Visualization Evaluation Product (Delano 
Scientific LLC). 
Cbf5 is the Catalytic Protein of Archaeal and Eukaryotic H/ACA snoRNPs  
Early characterization of Cbf5 strongly suggested that Cbf5 was the H/ACA snoRNP catalytic 
enzyme as Cbf5 shares significant sequence similarity with the E. coli pseudouridine synthase 
TruB and to the rat nucleolus protein NAP57 [33, 95-96]. In 1998 the Tollervey group confirmed 
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Cbf5 as the catalytic component of H/ACA snoRNPs, demonstrating that depletion of Cbf5 
results in the loss of pseudouridine formation and the reduction of H/ACA structural protein 
accumulation [14]. In addition, the Carbon group in 1999 further demonstrated that Cbf5 was 
indeed the catalytic residue of H/ACA snoRNPs using mutational studies in which the proposed 
catalytic aspartate residue was mutated [97]. Biochemical disruption studies and 
immunoprecipitation assays of eukaryotic H/ACA snoRNPs indicated that Cbf5 forms specific 
interactions with H/ACA snoRNAs and the H/ACA structural proteins Gar1, Nhp2, and Nop10, 
in which each set of H/ACA proteins may potentially interact with both H/ACA snoRNA hairpins 
(Fig. 13) [14, 31, 91]. Biochemical studies and crystallographic analysis indicate that Cbf5 
interacts independently with both Nop10 and Gar1, while the recruitment of structural protein 
Nhp2 is contingent on the formation of a Cbf5-Nop10 complex [24, 46, 91]. 
 
Figure 13: Proposed model of a eukaryotic H/ACA snoRNP complex. Studies of the archaeal H/ACA 
snoRNP system suggest that the H/ACA core components will interact in a similar manner in eukaryotes as 
they do in archaea, with a copy of the core H/ACA proteins assembling at each hairpin motif of the 
snoRNA. 
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H/ACA Structural Protein Nop10 Interacts with the Catalytic Domain of Cbf5 
H/ACA structural protein Nop10 is a small two-domain protein consisting of an N-terminal β-
domain with two closely packed β-hairpins and a C-terminal α-helix domain [15, 35]. The two 
domains are connected by a highly conserved, unstructured linker region forming a random coil. 
On its own, Nop10 is a disordered protein; however, upon binding to Cbf5, Nop10 becomes 
highly structured, interacting with both Cbf5’s catalytic D1 and D2 subdomains [15, 24, 35]. 
Many highly conserved residues within the linker region of Nop10 associate with residues in 
Cbf5 which are also highly conserved [35]. The C-terminal α-helix of Nop10 interacts with 
Cbf5’s D1 α6 helix forming a coiled-coil, while the N-terminal β-domain of Nop10 associates 
with Cbf5’s β10-β12 central β-sheet [15, 24]. The interactions formed between Nop10’s C-
terminal domain and the D1 subdomain of Cbf5 within eukaryotes are required for both the 
association of H/ACA structural protein Nhp2 and stable binding of the H/ACA snoRNA and 
substrate RNA [15]. The association of Nop10 to Cbf5 enables a universally conserved lysine 
residue of Cbf5 to form hydrogen bonds with Cbf5’s catalytically aspartate residue forming a 
catalytic active Cbf5 enzyme. This suggests that Nop10 could act as a molecular switch between 
catalytically active and inactive forms of Cbf5, thereby modulating the enzymatic dynamics of 
the active site of Cbf5 [35].  
H/ACA Structural Protein Gar1 Interacts with the Catalytic Domain of Cbf5 
H/ACA structural protein Gar1 is a member of the reductase, isomerase and elongation factor 
fold superfamily, containing a characteristic six-stranded β-barrel structure. Gar1 interacts with 
Cbf5’s catalytic subdomain D2. Gar1’s β1/β2 loop and β4/β5 loop associate with Cbf5’s β7/β10 
hairpin loop [15]. The β7/β10 hairpin loop of Cbf5 (also called the thumb loop) contains a highly 
conserved arginine rich region [25]. The thumb loop of Cbf5 plays an essential role in substrate 
recruitment and release, undergoing a conformational change between a substrate-free Gar1-
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bound open state to a substrate-bound loading state [25]. Mutational studies of Gar1 have shown 
that depletion of Gar1 not only prohibits product release after catalysis, but also inhibits substrate 
loading and further catalysis, supporting the idea that Gar1 plays a critical role in substrate 
loading and turnover [25]. 
Cbf5 Interacts with H/ACA snoRNAs 
As previously mentioned, H/ACA snoRNAs fold into a characteristic secondary structure: 
eukaryotic H/ACA snoRNAs contain two irregular hairpin structures, linked by a hinge sequence 
(Box H) followed by a short 3’ tail (Box ACA) [23, 98]. Box H, following the 5’ hairpin, consists 
of an ANANNA sequence; while Box ACA, located three nucleotides upstream of the 3’ end, 
consists of an ACA sequence [89]. Each hairpin structure contains a large internal loop, the 
pseudouridylation pocket, which is complementary to the substrate RNA [23, 26]. H/ACA 
snoRNAs make several critical contacts with the H/ACA protein complex, specifically with 
Cbf5’s catalytic domain and PUA domain. The snoRNA binds along the front face of the protein 
complex, where the upper hairpin structure interacts with the composite surface of Cbf5-Nop10-
L7Ae (Nhp2 in eukaryotes) while the lower hairpin structure and the ACA sequence is bound by 
Cbf5’s PUA domain [24]. The binding of the snoRNA on either end anchors the snoRNA on the 
protein complex, positioning the pseudouridylation pocket in close proximity to Cbf5’s active site 
cleft [24].  
Dyskeratosis Congenita and Cbf5  
H/ACA snoRNPs have been linked to the rare inherited disease DC. DC is a clinically and 
genetically heterogeneous disease and is characterized by premature aging, nail dystrophy, 
mucosal leukoplakia, an increased chance of malignancies, and often fatal bone marrow failure 
[99]. To date three forms of Dyskeratosis congenita have been characterized: X-linked, autosomal 
dominant and autosomal recessive. X-linked, the most common and severe form, is attributed to 
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point mutations within the human homolog of Cbf5, dyskerin [70]. The majority of these DC 
mutations have been mapped to the PUA domain of Cbf5 with additional mutations being 
localized to the catalytic domain [15, 24, 35]. The DC substitutions within the PUA domain of 
Cbf5 form a spatial mutational cluster [15, 24, 35]. While the effect of such a mutational hot spot 
is not fully understood, it is believed that these substitutions either directly disrupt Cbf5’s 
interaction with H/ACA snoRNAs or compromise the structural stability of Cbf5 [15, 24]. A 
recent publication by the Meier group showed that DC substitutions within NAP57 (the rat 
homolog of Cbf5) affect the interaction between NAP57 and the H/ACA snoRNP accessory 
protein SHQ1 [100]. DC substitutions in NAP57 causes an imbalance in the NAP57-SHQ1 
interaction which may result in the sequestering, improper folding or degradation of newly 
synthesized NAP57 [100]. This would directly lead to the impairment of H/ACA snoRNP 
biogenesis which in turn could be also connected to a decrease in H/ACA snoRNP accumulation 
[100].    
III.II Objective 
H/ACA small ribonucleoproteins (RNPs) catalyze the formation of pseudouridines in many 
different RNAs in archaea and eukaryotes. The H/ACA RNP complex is comprised of four highly 
conserved core proteins, Cbf5, Gar1, Nop10, and L7ae (archaea), as well as one of several 
different H/ACA snoRNAs. The H/ACA snoRNA guides substrate RNA modification by site-
directed base-pairing while Cbf5 catalyzes pseudouridylation. Mutations in Cbf5 have been 
shown to cause the rare X-linked disease Dyskeratosis congenita. In eukaryotes, pseudouridine 
formation plays an essential role in pre-ribosomal RNA processing. The modification of rRNA is 
the first important step after transcription in the overall process of ribosome biogenesis. Despite 
its importance, the detailed mechanism of pseudouridine formation by H/ACA RNPs is not fully 
understood. To understand the mechanism of H/ACA RNPs, it is necessary to gain detailed 
knowledge of how the components interact with one another.  
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 Much of what is currently known and hypothesized about eukaryotic H/ACA snoRNPs 
has been obtained from the in vitro study of the homologous archaeal H/ACA sRNP complex. 
While this information is invaluable, fundamental questions regarding stoichiometry, association, 
and catalytic efficiency of H/ACA snoRNPs have yet to be answered within a eukaryotic system. 
The reconstitution of a functionally active S. cerevisiae H/ACA snoRNP complex will allow us to 
address these essential, unanswered questions using powerful in vitro studies. As Cbf5 is the 
central catalytic protein within H/ACA snoRNPs, it is critical that we begin to understand how 
Cbf5 interacts with the other H/ACA snoRNP components. To study such interactions, a 
recombinant S. cerevisiae Cbf5 protein must first be successfully expressed and purified.  
III.III Materials and Methods 
Molecular cloning of H/ACA catalytic protein Cbf5 
The gene encoding H/ACA catalytic protein Cbf5 was amplified from S. cerevisiae genomic 
DNA and a 5’-EcoRI and 3’-HindIII restriction sites were introduced by PCR using the following 
primer pairs:  
 Cbf5 F: GAATTCGTCAAAGGAGGATTTCGTTATTA 
 Cbf5 R: AAGCTTTCATTTCTTAGATTTCTTAGATTTCC 
PCR reactions were carried out in 50 µL volumes with final concentrations as follows: 1x Pfu 
buffer with MgSO4, 200 µM dNTPs, 0.5 µM of each primer, 0.02 U/µL Pfu DNA polymerase, 
and 2.0 µL S. cerevisiae genomic DNA. PCR cycle parameters included an initial denaturation at 
98 
o
C for 5 min followed by 5 cycles of denaturation at 98 
o
C for 30 s, touch-up annealing 
starting for 30 s at 41.5 
o
C with a 1 °C increase in each cycle, and extension at 72 °C for 1 min, 
with an additional 30 cycles of denaturation at 98 
o
C for 30 s, annealing at 46.5 
o
C for 30 s, and 
extension at 72 
o
C for 1 min followed by a final extension at 72 
o
C for 10 min. PCR products 
were analyzed on a 1% agarose gel and visualized by ethidium bromide staining. The PCR 
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product was purified with an EZ-10 Spin Column PCR Products Purification Kit (Bio Basic Inc.), 
following the manufacturer’s instructions and blunt end ligated into the SmaI cleaved cloning 
vector pUC19 [88]. Ligated pUC19-ScCbf5 was transformed into competent high-efficiency E. 
coli DH5α cells (NEB). Transformation mixtures were plated on X-Gal-treated LB agar plates 
containing 0.1 mg/mL ampicillin [88]. Plates were incubated overnight at 37 °C. White E. coli 
colonies (positive for gene insertion) were transferred into 5 mL of LB containing 0.1 mg/mL 
ampicillin and grown overnight at 37 
o
C. Plasmid DNA from the resulting cell cultures was 
isolated using an EZ-10 Spin Column Plasmid DNA Minipreps Kit (Bio Basic Inc.), following 
the manufacturer’s instructions. Isolated plasmid DNA was tested for positive gene insertion 
through restriction digestion with EcoRI. 20 µL restriction digestion reactions with pUC19-
ScCbf5 (EcoRI) were incubated at 37 
o
C for 2 hr with final component concentrations of: 1x 
Tango Buffer (Fermentas), 2 µg pUC19-ScCbf5 plasmid DNA, and 2 U/µL EcoRI restriction 
enzymes (Fermentas). Restricted plasmids were analyzed on a 1% agarose gel at 110 V for 1hr 
and visualized with ethidium bromide staining [88]. Clones appearing to be positive were sent to 
Macrogen Inc. for sequencing. Positively sequenced clones were then maxiprepped and used for 
further molecular cloning of CBF5. 
 pUC19-Cbf5 plasmid DNA was purified with EZ-10 Spin Column PCR Purification Kit 
(Bio Basic Inc.). CBF5 was then PCR amplified with a primer pair introducing a 5’- BamHI and 
3’- EcoRI restriction site (underlined in primer sequences) at the 5’ and 3’ end of the Cbf5 gene: 
 Cbf5F:  CGTGGGATCCCCTCAAAGGAGGATTTCGTTATTA 
 Cbf5 R: CCGGGAATTCTCATTTCTTAGATTTCTTAGATTTC 
PCR reactions were carried out in 50 µL volumes with final concentrations as specified above. 
PCR cycle parameters included an initial denaturation at 98 
o
C for 5 min followed by 6 cycles of 
denaturation at 98 
o
C for 30 s, touch-up annealing starting for 30 s at 48 
o
C with a 1 °C increase 
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in each cycle, and extension at 72 °C for 1 min, with an additional 30 cycles of denaturation at 95 
o
C for 30 s, annealing at 53 
o
C for 30 s, and extension at 72 
o
C for 1 min followed by a final 
extension at 72 
o
C for 10 min. PCR products were once again analyzed on a 1% agarose gel and 
visualized by ethidium bromide staining and purified using an EZ-10 Spin Column PCR Products 
Purification Kit (Bio Basic Inc.) [88]. Purified CBF5 was restricted with EcoRI and BamHI 
restriction enzymes (Fermentas) in a 100 µL reaction volume for 4 hours at 37 
o
C with a final 
components concentration of: 2X Tango Buffer (Fermentas), 2 µg CBF5, 2 U/µL EcoRI 
restriction enzyme (Fermentas), 4 U/µL BamHI restriction enzyme (Fermentas). pGEX-5x-3 
plasmid was restricted in the same manner and was subsequently gel extracted using a Silica 
Bead DNA Gel Extraction kit (Fermentas) following the manufacturer’s instructions. Purified 
Cbf5 was sticky end ligated into purified EcoRI and BamHI restricted expression vector pGEX-
5X-3 [88]. Ligated pGEX-5X-3-Cbf5 was subsequently transformed into high-efficiency 
competent E. coli DH5α cells (NEB) and plated on LB agar containing 0.1 mg/mL ampicillin. 
Plates were incubated overnight at 37 
o
C from which resulting colonies were selected and grown 
overnight once again at 37 
o
C in 5 mL LB. Plasmid DNA from the selected colonies was isolated 
by miniprep as described previously and subjected to EcoRI restriction digestion to confirm for 
positive clones. 20 µL EcoRI restriction volumes were incubated at 37 
o
C for 1 hr and analyzed 
by 1% agarose gel electrophoresis (both as previously discussed). Plasmids positive for CBF5 
insertion were sent to Macrogen Inc. for sequencing. 
Optimization of Cbf5 recombinant expression  
E. coli BL21 (DE3) Rosetta cells containing the pGEX-5x-3-ScCbf5 plasmid were grown 
overnight at 37
o
C in 100 mL of LB medium (1% (w/v) tryptone, 0.5% (w/v) yeast extract, and 
1% (w/v) NaCl pH 7.0) containing 0.1 mg/mL of ampicillin. Cells were pelleted and resuspended 
in 50 mL of fresh LB medium containing 0.1 mg/mL of ampicillin. Subsequently, 2 L of LB 
medium containing 0.1 mg/mL of ampicillin were inoculated to a cellular density of 
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approximately 0.1 OD600. Cell cultures were incubated at 37
o
C and the OD600 was recorded every 
hour. Once a cellular density of 0.4 OD600 was reached, 1 mM of IPTG was added to induce 
expression of GST-Cbf5 fusion protein. The cell density was recorded for three additional hours 
with cell samples of 1 OD600 being taken at times 0 hr, 0.5 hr, 1.0 hr, 2.0 hr, and 3.0 hr after 
induction. After 3 hr of growth, cell cultures were pelleted by centrifugation, shock frozen with 
liquid nitrogen and stored at -80 
o
C. Cell samples were suspended in 80 µL of cell lysis buffer 
(0.1 M Tris-HCl pH 8.5 containing 8 M urea) and boiled for 5 minutes at 95 
o
C to open cells. A 
cellular sample containing GST-tagged Cbf5 was also taken and subjected to solubility testing. 
All samples were analyzed by 12 % SDS-PAGE and visualized using Coomassie stain.  
 To optimize GST-Cbf5 protein solubility at the expression level, the temperature of cell 
growth was reduced to 20 
o
C and 2% ethanol was added prior to induction. E. coli BL21 (DE3) 
Rosetta cells containing the pGEX-5x-3-ScCbf5 plasmid were grown and prepared for 
recombinant expression in the same manner as discussed above. Cultures were placed into a 
refrigerated cell growth chamber 1 hr prior to IPTG induction and equilibrated to a temperature of 
20 
o
C. Immediately preceding induction, cell cultures were treated with 2% ethanol to cause 
cellular stress. Upon induction with IPTG, cells were permitted to grow for an addition 17 hr at 
20 
o
C, with cell density reading and cell samples taken at times 1 hr and at 17 hr after induction. 
A cellular sample containing GST-tagged Cbf5 was taken and subjected to solubility testing. All 
samples were again prepared and analyzed as previous described.  
Solubility Testing of GST-Cbf5 
1 g of E. coli BL21 (DE3) Rosetta cells containing GST-tagged Cbf5 was resuspended in 3 mL of 
cell lysis buffer (50 mM Tris-Cl (pH 8.0), 1 mM EDTA, 10 mM NaCl). 0.13 mM PMSF and 0.27 
mg/ml lysozyme was added to resuspended cells and incubated for 20 min at 4 
o
C. 4 mg of 
sodium deoxycholate was then added followed by incubation for an additional 10 min at 4 
o
C. 
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Once the cell lysate has become viscous, 0.0067 mg/ml DNase I was added followed by 
incubation until the cell lysate was no longer viscous (~30 min). The cell lysate was centrifuged 
at 14,000 rpm for 15 min at 4°C. The isolated supernatant was saved for SDS-PAGE analysis as 
the soluble protein fraction. The pelleted cell debris was washed with 1 mL H20 and resuspended 
in 1 ml of 0.1 M Tris-Cl (pH 8.5) containing 8 M urea. Solubilized protein was separated from 
remaining insoluble protein through centrifugation, where the resulting supernatant was saved for 
SDS-PAGE analysis as the urea-dissolved fraction. The remaining insoluble fraction was 
resuspended in 1 mL H20 and saved for SDS-PAGE analysis as the insoluble inclusion body 
fraction. All saved samples were analyzed by 12% SDS-PAGE for the presence of GST-Cbf5.   
Optimization of Cbf5 Purification  
Recombinantly expressed, GST-tagged Cbf5 was initially purified by glutathione-sepharose 
affinity chromatography. E. coli BL21 (DE3) Rosetta cells containing GST-tagged Cbf5 were 
resuspended in cell lysis buffer (1 mL/g of cells) containing: 50 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 10 mM MgCl2, 0.5 mM EDTA, 0.1 mM PMSF, 1 mM β-Mercaptoethanol and 5% 
glycerol. 1 mg/ml lysozyme and 12.5 mg/g (of cells) of sodium deoxycholate were then added to 
the resuspended cells. Cells were opened by sonication using an intensity level of 6, and duty 
cycle of 60% for 1 min repeated 5 times. The cell debris was pelleted at 30 000 xg for 30 min at  
4 
o
C. The cleared cell lysate was incubated with 5 mL of glutathione-sepharose (GE Healthcare) 
for 1 hr at room temperature. All unbound protein was removed by washing of the glutathione 
sepharose with 3 times the column volume of cell lysis buffer, through centrifugation at 500 xg 
for 5 min at 4 
o
C. The washing step was repeated 5 times. GST-Cbf5 was eluted from the 
glutathione sepharose with ½ the column volume of elution buffer (50 mM Tris-HCl, pH 8.0, 10 
mM reduced glutathione, and 10% glycerol) incubated for 10 min at room temperature. Eluted 
GST-Cbf5 was isolated from the glutathione sepharose through centrifugation at 500 xg for 5 min 
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at 4 
o
C. GST-Cbf5 elution was repeated 6 times. 50 µL samples were collected throughout the 
purification procedure and were analyzed as previous described. 
 To optimize the solubility of GST-Cbf5 during purification, sarkosyl, CHAPS and triton 
X-100 were added to the purification buffers. Cell lysis and opening was performed as previously 
described. The cellular debris pellet containing insoluble GST-Cbf5 was resuspended in 15 mL of 
cell lysis buffer containing 10% (w/v) sarkosyl and incubated for 15 min at room temperature. 
Solubilized GST-Cbf5 was separated from remaining insoluble cell debris through centrifugation 
at 30 000 xg for 30 min at 4 
o
C. The resulting supernatant was then diluted 1:10 with cell lysis 
buffer, thereby diluting the sarkosyl concentration to 1% (w/v). 2% (v/v) Triton X-100 and 20 
mM CHAPs was subsequently added to the diluted supernatant. The diluted supernatant was 
incubated with 5 mL of glutathione-sepharose (GE Healthcare) for 1 hr at room temperature. All 
unbound protein was removed through the washing of the glutathione sepharose with 3 times the 
column volume of cell lysis buffer containing 1% (w/v) sarkosyl, 2% (v/v) Triton X-100 and 2 
mM CHAPS for the first 2 washes, while cell lysis buffer containing 1% (v/v) Triton X-100 and 
10% (v/v) glycerol was used for the last 3 washes. Wash solution and glutathione sepharose resin 
were separated through centrifugation at 500 xg for 5 min at 4 
o
C. GST-Cbf5 was eluted from the 
glutathione sepharose with ½ the column volume of elution buffer (50 mM Tris-HCl, pH 8.0, 10 
mM reduced glutathione, 10% glycerol, and 0.5% (v/v) Triton X-100) incubated for 10 min at 
room temperature. Eluted GST-Cbf5 was isolated from the glutathione sepharose through 
centrifugation at 500 xg for 5 min at 4 
o
C. The elution of GST-Cbf5 was repeated 6 times. 50 µL 
samples were collected throughout the purification procedure and were prepared and analyzed as 
previous described. 
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III.IV Results 
Optimization of the recombinant expression of S. cerevisiae H/ACA protein Cbf5 
In an effort to optimize the recombinant expression efficiency and protein solubility of S. 
cerevisiae H/ACA catalytic protein Cbf5, multiple protein expression conditions were tested. For 
comparison, the growth of E. coli BL21 (DE3) Rosetta cells containing the plasmid pGEX-5x-3-
ScCbf5 was monitored at 37 °C for seven hours, at 20 °C for seven hours and at 20 
o
C in the 
presence of two percent ethanol for seventeen hours (Fig. 14D). A protein solubility test was 
subsequently performed to determine the effect of the different cell growth conditions of E. coli 
BL21 (DE3) Rosetta cells on GST-Cbf5 protein solubility. The solubility test separates the 
soluble, urea-soluble and insoluble protein fractions. Samples were collected during each protein 
expression step and throughout the protein solubility test and were then analyzed by SDS-PAGE.  
 First, expression and solubility levels of GST-Cbf5 were tested at 37 °C, i.e. at standard 
expression conditions in E. coli. As shown in Figure 14A, a band of ~80 kDa increases in 
intensity over a three hour time period, indicating that recombinant expression of GST-Cbf5 is 
successful at 37 °C. However, samples analyzed from the subsequent solubility test (Fig. 14A) 
indicated that GST-Cbf5 is predominantly in the insoluble pellet and urea dissolved fraction. In 
an effort to increase the solubility of GST-Cbf5, two cellular growth conditions were varied: the 
temperature at which the cells were grown upon induction was lowered, and the addition of 
ethanol upon induction was tested as well.  
 Recombinant expression at lower temperatures was first tried as it has been well 
documented that lower cell growth temperatures reduces cellular growth (observed in Fig. 14D) 
resulting in the slowing of all cellular processes including protein folding. While the use of a 
lower temperature appears to increase GST-Cbf5 solubility, some protein was still observed in the 
insoluble fraction (Fig. 14B). The introduction of ethanol during recombinant expression has been 
reported to induce cellular stress which is thought to enhance the expression of chaperones to 
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assist in protein folding [101-102]. The utilization of both lower cell growth temperatures and the 
introduction of ethanol during protein expression were believed to further aid in the folding of 
GST-Cbf5 and thus improve the solubility of the protein. As both reduced growth temperatures 
and the addition of a foreign stress appear to affect the rate of cellular growth (Fig. 14D), cells 
were permitted to grow for seventeen hours after induction. Analysis of the cellular samples 
collected during protein expression and during the solubility test indicate that prolonged cellular 
growth increases GST-Cbf5 expression levels and that the combination of a reduced growth 
temperature and the addition of two percent ethanol increases protein solubility levels (Fig. 14C).   
Optimization of the purification of S. cerevisiae H/ACA protein Cbf5 
As previously discussed, GST-Cbf5 is predominantly found within the insoluble cell pellet when 
expressed at standard 37 
o
C conditions, presenting a significant problem in the purification of the 
fusion protein. To address this problem at the protein expression level, all cells were grown for 
seventeen hours at 20 
o
C and in the presence of two percent ethanol. GST-tagged Cbf5 was 
subsequently purified using glutathione sepharose affinity chromatography.  
 E. coli BL21 (DE3) Rosetta cells containing GST-Cbf5 were opened in a cell lysis buffer, 
and the resulting cellular lysate was incubated with glutathione-sepharose affinity 
chromatography matrix. Following washing with cell lysis buffer, GST-Cbf5 was subsequently 
eluted from the glutathione sepharose with elution buffer containing reduced glutathione. 
Samples were taken at every step during the purification procedure and were analyzed by SDS-
PAGE. A band of approximately 80 kDa corresponding to GST-Cbf5 was expected to be 
observed throughout the purification; however, a band of 80 kDa was only observed within the 
insoluble cellular pellet (Fig. 15A). This indicates that insufficient amounts of GST-Cbf5 are 
soluble for protein purification. 
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Figure 14: Optimization of the recombinant expression of S. cerevisiae Cbf5 in E. coli. A. 
Recombinant expression at 37 oC and solubility test of GST-Cbf5 wild-type in E. coli BL21 (DE3) Rosetta 
cells. Cell samples were taken for three hours after induction and analyzed by 12 % SDS – PAGE. GST-
Cbf5 fusion protein has a molecular weight of ~80 kDa. Soluble cell lysate (S), the urea-dissolved fraction 
of the cell pellet (U) and the insoluble fraction (I) were analyzed by 12% SDS-PAGE. MWM: molecular 
weight marker. B. Recombinant expression at 20 oC and solubility test of GST-Cbf5 wild-type. Cell 
samples were taken at induction and for three hours after induction and analyzed by 12 % SDS – PAGE. 
The solubility of expressed GST-Cbf5 was analyzed as before. C. GST-Cbf5 wild-type recombinant 
expression at 20 oC with the addition of 2% ethanol. Cell samples were taken upon induction and seventeen 
hours after induction and analyzed by 12 % SDS – PAGE. The solubility of expressed GST-Cbf5 was 
analyzed as before. D. Cellular growth rates of E. coli BL21 (DE3) Rosetta cells under the three growth 
condition were plotted to compare cellular growth rates. Cell growth at 37 oC (circles), at 20 oC (triangles), 
and at 20 oC with 2% ethanol (squares).  
  While the GST-Cbf5 protein solubility was significantly improved by expression at 
decreased temperatures and the addition of two percent ethanol, the solubility was still not 
sufficient to obtain detectable amounts of GST-Cbf5 after purification by glutathione sepharose 
affinity chromatography. In an effort to optimize GST-Cbf5 purification, a combination of 
detergents, sarkosyl, CHAPS and Triton X-100, were employed as this detergent combination had 
been previously reported to aid in protein solubility during purification of GST-fusion proteins 
[103]. The cell pellet was first treated with sarkosyl in order to solubilize GST-Cbf5 (Fig. 15B, 
lane Spt. AS). CHAPS and Triton X-100 were subsequently added to the newly solubilized fusion 
protein enabling GST-Cbf5 to quantitatively bind to the glutathione sepharose chromatography 
column as confirmed by the lack of a GST-Cbf5 band in the supernatant after column binding 
(Fig. 15B, lane Spt. AB). The glutathione sepharose was washed with two different wash buffers 
in which the first contained all three detergents and the second contained only Triton X-100 and 
10% glycerol (Fig. 15B, lanes W1-5).  Two wash buffers differing slightly in their composition 
were used in hope of maintaining GST-Cbf5 solubility while removing all unbound proteins. 
GST-Cbf5 was then eluted with an elution buffer containing reduced glutathione; however, SDS-
PAGE analysis of samples taken from the elution step did not reveal any GST-Cbf5 (Fig. 15B, 
lanes E1-4). 
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Figure 15: Optimization of the purification of S. cerevisiae Cbf5. A. Glutathione sepharose affinity 
chromatography purification of GST-Cbf5 fusion protein using standard purification conditions (described 
in Materials and Methods). During the purification, samples were collected from the cell lysate (CL), cell 
pellet (CP), supernatant after resin binding (Spt. AB), washes (W), and elutions (E) and analyzed by 12 % 
SDS-PAGE. B. Glutathione sepharose affinity chromatography purification of GST-Cbf5 fusion protein 
using the detergent sarkosyl to extract GST-Cbf5 from the cell pellet, and the detergents CHAPs and 
Triton-X-100 to increase GST-Cbf5’s solubility in the binding and washing buffer (for details see Materials 
and Methods). Samples were taken throughout the purification and analyzed: supernatant after sarkosyl 
treatment (Spt. AS), cell pellet after sarkosyl treatment (CP. AS), and a resin sample taken after GST-Cbf5 
elutions (RS). C. The glutathione sepharose column after the purification shown in B. was treated with 1% 
Triton X-100 to remove all unspecifically bound proteins. A sample was taken from supernatant after 
Triton X-100 treatment (TE) and compared with samples taken during GST-Cbf5 over-expression and with 
a sample taken from the pool GST-Cbf5 elutions (PE).  
 In contrast, analysis of a sample of the glutathione sepharose resin showed that a 
significant amount of GST-Cbf5 remained on the resin despite treatment with reduced glutathione 
(Fig. 15B, lane RS), suggesting that GST-Cbf5 was non-specifically aggregating on the 
glutathione sepharose column. This hypothesis could be confirmed by treatment of the 
glutathione sepharose resin with 1% Triton X-100 which denatured and solubilised GST-Cbf5 
 73 
 
(Fig. 15C). In summary, this experiment shows that GST-Cbf5 can be successfully solubilized 
from the cell pellet by sarkosyl and that it binds to the glutathione sepharose column under the 
described conditions. The elution step remains to be optimized as GST-Cbf5 seems to precipitate 
on the glutathione column during the washing steps which gradually remove the detergents 
(sarkosyl and CHAPS).    
III.V Discussion 
Optimization of recombinant expression of GST-Cbf5 fusion protein 
Recombinant expression of proteins in E. coli is dependent on numerous features throughout the 
process of gene expression including the transcription of a stable mRNA transcript containing a 
correct translation initiation start site and the proper translation and folding of polypeptide chains 
into functional proteins structures [104-105]. However, high levels of expression in E. coli often 
lead to the aggregation of recombinant proteins as insoluble inclusion bodies as a result of 
improper protein folding. Like many other eukaryotic proteins, recombinantly expressed in E. 
coli, GST-Cbf5 experienced significant issues with protein solubility levels as the majority of 
GST-Cbf5 was found within insoluble inclusion bodies. GST-Cbf5 was expressed in E. coli BL21 
(DE3) Rosetta cells. BL21 (DE3) Rosetta cells contain the genes for tRNA argU, argW, ileX, 
glyT, leuW, proL, metT, thrT, tyrU, and thrU and provide supplementation for the rare eukaryotic 
codons AGG, AGA, AUA, CUA, CCC, and GGA. Expression of GST-Cbf5 in E. coli BL21 
(DE3) Rosetta cells at standard 37 
o
C expression conditions was not sufficient to produce soluble 
protein, as the majority of GST-Cbf5 remained in the insoluble inclusion body fraction.    
 It has been previously reported that the addition of approximately two percent ethanol to 
E. coli cells during recombinant protein expression can increase the production of soluble 
recombinant proteins [101]. It is believed that the addition of ethanol increases cellular stress 
levels within the E. coli cells resulting in the increased production of E. coli chaperonins GroEL 
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and GroES [101]. High concentrations of chaperones within the cell would increase the potential 
for the correct folding of newly synthesized proteins, thus increasing the production of soluble 
recombinant proteins. It has also been reported that the reduction of cellular growth temperatures 
during protein expression can assist in the synthesis of soluble recombinant proteins. The 
reduction of cellular growth temperatures slows replication, transcription and translation in the 
cell while increasing the activity and expression levels of many E. coli chaperones [102]. The 
slowing of cellular processes and the increase in chaperone availability at reduced growth 
temperature provides a more stable environment for protein expression with a greater potential 
for efficient protein folding [102]. Accordingly, the expression of GST-Cbf5 under reduced 
cellular growth temperatures and with the addition of two percent ethanol significantly improved 
the solubility of the recombinant fusion protein. However, as a result of the lower growth 
temperature, the duration of recombinant protein expression had to be extended from three hours 
to seventeen hours to allow an adequate amount of GST-Cbf5 to be produced.  
 Another possible approach to increasing the synthesis of soluble GST-Cbf5 fusion 
protein is to co-express GST-Cbf5 with one of the H/ACA snoRNP early accessory proteins 
which interact only with free Cbf5. H/ACA accessory proteins Shq1 and Naf1 have both been 
reported to interact exclusively with Cbf5 stabilizing the free Cbf5 and potentially assisting in the 
proper folding of the protein [43-45, 48, 49]. Co-expression of either Shq1 or Naf1 with GST-
Cbf5 may increase GST-Cbf5 protein solubility by associating with newly synthesized GST-
Cbf5. Neither Shq1 nor Naf1 are part of the mature H/ACA snoRNP complex as both accessory 
proteins are removed from Cbf5 either upon snoRNA binding (Shq1) or upon Gar1 association 
(Naf1) [43-45, 48, 49]. This would potentially allow for the successful expression and 
purification of a stable GST-Cbf5-Shq1 or GST-Cbf5-Naf1 complex, which can be used for both 
interaction studies and H/ACA snoRNP complex recombination as both accessory proteins could 
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potentially be selectively removed by addition of snoRNA or Gar1, respectively. The GST 
domain could be removed by site-specific protease cleavage. 
Optimization of GST-Cb5 protein purification 
While the expression of GST-Cbf5 at reduced temperature and in the presence of two percent 
ethanol aided in the synthesis of soluble GST-Cbf5 fusion protein, the solubility effect noticeable 
during expression was not significant enough to prevent GST-Cbf5 from aggregating during 
glutathione sepharose affinity purification. A recent publication by the Massiah group reported 
the use of a combination of three detergents, sarkosyl, Triton X-100, and CHAPS, during protein 
purification of insoluble GST-fusion proteins to solubilize proteins aggregated in the insoluble 
cell pellet and thus to successfully purify soluble protein [103]. The Massiah group hypothesized 
that the addition of sarkosyl to the insoluble pellet disrupts protein aggregates by encasing the 
insoluble protein [103]. The addition of Triton X-100 and CHAPS reduces the concentration of 
sarkosyl around the protein by absorbing the sarkosyl molecules into large micelle structures 
allowing for protein folding [103]. The Massiah group speculated that the combination of the 
three detergents transfers the aggregated protein into a molten globule state [103]. This in turn 
would allow the protein a second chance at correct folding. Modification of the GST-Cbf5 
purification strategy to incorporate these detergents allowed for the successful solubilisation and 
purification of GST-Cbf5. However, upon removal of these detergents during washing and 
elution, GST-Cbf5 protein solubility was lost resulting in the precipitation of the protein onto the 
glutathione sepharose column. To circumvent this problem, the next logical step would be to 
incorporate sarkosyl, Triton X-100, and CHAPS in both the washing buffer and elution buffer. 
However, the presence of such detergents may affect future protein interaction studies. Therefore, 
extensive controls and trials will have to be performed to investigate if the detergents could be 
removed subsequent to elution or upon addition of other H/ACA components.  
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Future Directions 
 The successful purification of S. cerevisiae Cbf5 will allow for the investigation of how 
eukaryotic H/ACA snoRNP components interact with one another, and for the determination of 
their individual functional roles in establishing an active H/ACA snoRNP structure. H/ACA 
snoRNPs are intricately involved in critical cellular processes through post-transcriptional 
modifications, cleavage events, and RNA maturation. The detailed functional mechanism of 
H/ACA snoRNPs is however unknown as a functionally active eukaryotic H/ACA snoRNP 
complex has yet to be successfully produced in vitro. The ability to successfully reconstitute a 
functionally active H/ACA snoRNP complex in yeast would provide a model system in which the 
full extent of H/ACA snoRNP involvement in ribosome biogenesis, mRNA splicing and telomere 
maintenance could be studied.    
 The establishment of a yeast H/ACA snoRNP system would also allow for the direct 
analysis of the effect DC mutations within H/ACA snoRNP components have on ribosome 
biogenesis. The amino acid positions at which DC substitutions are found in the human dyskerin 
protein are conserved in yeast allowing us to study the effects such mutations have at a diploid 
and haploid level in vivo and hopefully in future also in vitro. As DC is often associated with men 
carrying a DC mutation on their single X-chromosome, the use of haploid S. cerevisiae cells 
should display similar symptoms as male patients with a DC mutation while it would be expected 
that diploid S. cerevisiae cells would exhibit a similar asymptomatic behaviour as heterozygous 
females [99].  
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